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Background: Sleep-Disordered Breathing (SDB) varies from habitual snoring to partial or 
complete obstruction of the upper airway, and can be found in up to 10% of children. SDB can 
significantly affect children’s wellbeing, as it can cause growth disorders, educational and 
behavioural problems, and even life-threatening conditions, such as cardiorespiratory failure. 
Adenotonsillectomy represents the primary treatment for paediatric SDB where adeno-tonsillar 
hypertrophy is indicated. For those with craniofacial anomalies, for whom adenotonsillectomy 
or other treatment modalities have failed, or surgery is contra-indicated, mandibular advancement 
splints (MAS) may represent a viable treatment option. Whilst the efficacy of these appliances 
has been consistently demonstrated in adults, there is little information about their effectiveness 
in children. 
Study objective: The aims of this research are first, to define the most accepted appliance from 
different designs of MAS to be used in the main study and second, to determine the efficacy of 
mandibular advancement appliances (MAS) for the management of Sleep-Disordered Breathing 
(SDB) and related health conditions in children.  
Methods: The first part of this research was a pilot study designed as a randomized controlled 
study with crossover application of four different MAS designs.  Questionnaires filled out by the 
patient and parent were used to gauge effectiveness of the different MAS designs regarding: the 
effects on speech, the initial acceptance, and the acceptance after wearing the appliance for a full 
night. A clinical examination then followed to test the appliance retention. One volunteer (11 
year old male with class II dental and skeletal jaw relationships) participated in this pilot study 
and he was suitable for functional appliance treatment. Appliances tested were: 1) traditional 
Twin-Block with vertical elastics added to ensure the anteroposterior and vertical predetermined 
position of the mandible when wearing the appliance during sleep; 2) Twin-Block with a metallic 
fastener in the anterior area to test the function of mandibular advancement; 3) Clear elastic Twin-





formed retainers instead of the acrylic material; 4) a sham Twin-Block with upper and lower 
vacuum formed retainers without any mandibular repositioning. This pilot study showed that 
traditional Twin-Block was the best design to be used in the main study as it was highly accepted 
by the patient and showed the highest levels of retention in comparison to the other designs.  
The main study was designed as a single-blind crossover randomised controlled trial with 
administration of both an ‘Active MAS’ (Twin-block) and a ‘Sham MAS’ (two Hawley 
retainers). Eligible participants were children aged 8 to 12 years, whose parents reported them 
snoring ≥ 3 nights per week. Exclusion criteria included class III incisor and/or skeletal 
relationship, confirmed by lateral cephalometric radiograph. 18 children participated in the study. 
Each child was randomly assigned to a treatment sequence, starting with either the Active or the 
Sham MAS. Participants wore the appliances for three weeks, separated by a two-week washout 
period. For each participant, home-based polysomnographic (PSG) data was collected four times, 
once before and once after each treatment period. The Apnoea Hypopnoea Index (AHI) 
represented the main outcome variable. Secondary outcomes, assessed at the same time with PSG 
recordings, included serum levels of Insulin-like Growth Factor 1 (IGF-1), obstructive sleep-
related breathing symptoms, as assessed by the Paediatric Sleep Questionnaire (PSQ), quality of 
life, as assessed by the OSA-18 questionnaire, and childhood behaviour, as assessed by the 
Behavioural Assessment System for Children (BASC-2) Behavioural and Emotional Screening 
System (BESS), and nocturnal enuresis. In addition, blood samples were collected at the end of 
each treatment period to assess growth hormone changes by measuring blood levels of insulin-
like growth factor-1 (IGF-1). 
Results: Compared to a Sham MAS, wearing an Active MAS resulted in a significant reduction 
in AHI of 40% (p=0.002) with a decrease in AHI when using the Active MAS, and a tendency 
for an increase in AHI when using the Sham MAS. The separate assessment of AHI in supine 
and non-supine sleeping positions revealed that only the former was significantly influenced by 
treatment, with a reduction of 4.1 events per hour (95% CI=1.8-6.4; p<0.001). Snoring time was 





p=0.004). The lowest oxygen saturation showed significant improvement of 3.4% (95% CI=0.9-
5.9; p=0.007) with the Twin-block in comparison to the Sham MAS. Compared to a Sham MAS, 
the Active MAS also reduced SDB symptoms. Subjective assessment by parents showed 
significant improvement, as represented by PSQ, OSA-18, and BASC-2 scores (p≤0.028). IGF-
1 levels, however, did not differ between the two treatment periods (p=0.172). There were no 
reports of nocturnal enuresis incidents during the study periods. 
Conclusion: The short-term use of mandibular advancement splints significantly reduced AHI, 
supine AHI. The decrease in the overall AHI resulted from a combination of a decrease in AHI 
when using the Active MAS, and a tendency towards an increase in AHI when using the Sham 
MAS. Snoring time decreased significantly when using MAS in children with SDB, and 
participants showed improvement in subjectively assessed SDB symptoms and quality of life. In 







The present work is divided into five main chapters that are organised as follows:   
Chapter 1 – Literature Review: This includes a general introduction and overview, describing 
the range of conditions of paediatric SDB, epidemiology, aetiology, and consequences of 
obstructive sleep apnoea. This introductory chapter also includes a review of the available 
diagnostic and treatment methods and focuses on the use of oral appliances in paediatric SDB 
treatment.  
Chapter 2 – Feasibility study and study protocol: (This Chapter was published as an original 
article in Frontiers in Physiology. 2016; 7(353)) The second chapter discusses 
methodological details of the present work. Results of a pilot study to choose the best design of 
MAS to be used in the study are presented in this chapter. However, the chapter also covers 
aspects of study design, sample size estimation, participant recruitment, and data collection and 
analysis, and discusses the significance of this study. The study protocol has been published in 
Frontiers in Physiology journal. 
Chapter 3 – Main study report: The main outcome of the overnight PSG results are presented, 
demonstrating changes in obstructive sleep apnoea with AHI and snoring as the measurements 
of interest. Secondary outcomes are discussed in this chapter, including Paediatric Sleep 
Questionnaire (PSQ), quality of life questionnaire (OSA-18), Parent reports of nocturnal enuresis 
and snoring frequency, insulin-like growth factor-1 (IGF-1) levels in the blood, and behavioural 
changes using the BASC-2 questionnaire. A more detailed account of the methods, analyses, and 
statistics used to investigate the study’s specific objectives is provided in this chapter.   
Chapter 4 – Discussion: This chapter provides further discussion of the current study results, 
limitations, future perspective, and conclusion. 
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SLEEP DISORDERED BREATHING IN CHILDREN 










1. Sleep disordered breathing in children: review of the 
literature 
4 Introduction 
Sleep is defined as physiological and behavioural states characterized by partial isolation 
from the environment1, or as a state of decreased responsivity to environmental stimuli that 
occurs on a regular basis2. A sleeping brain maintains a sentinel function to awaken the 
organism for protection purposes1.  
There is consensus today that sleep in terms of function is strictly linked to memory3, 
learning4 and, in general, to the mechanism of neural plasticity5. 
There are many sleep disorders, such as insomnia, hypersomnia, circadian rhythm sleep 
disorders, sleep-related breathing disorders and sleep-related movement disorders. Sleep-
related breathing disorders are the most common disorders involving dentists in terms of 
recognition and treatment6. 
5 Sleep physiology  
Normal sleep has an organised basic structure, it has two types: rapid eye-movement (REM) 
sleep, and non-rapid eye movement (NREM) sleep which consists of four stages identifying 
the sleep depth. Each of the sleep types has different characteristics including different brain 
wave patterns, muscle tone, and eye movement7 . A sleep episode starts with stage 1 of 




However, an individual does not stay in the REM for the rest of the night but will cycle 
between the stages of NREM and REM. The NREM takes 75-80% of the sleep with stage 2 
composing 45-55% of a sleep episode and the REM takes 20-25% of the sleep7. Table one 
summarises the physiological differences between NREM and REM sleep. 
 
Table 1 Physiological changes during NREM and REM sleep7-9  
Physiological Process NREM REM 
Brain activity  Decrease from wakefulness Increases in motor and 
sensory areas, while other 
areas are similar to NREM 
Heart rate Slows from wakefulness Increases and varies 
compared to NREM 
Blood pressure  Decreases from wakefulness Increases (up to 30 
percent) and varies from 
NREM 
Sympathetic nerve activity Decreases from wakefulness Increases significantly 
from wakefulness 
Muscle tone Similar to wakefulness Absent 
Blood flow to brain Decreases from wakefulness Increases from NREM, 
depending on brain region  
Respiration  Decrease from wakefulness Increases and varies from 
NREM, but may show 
brief stoppages coughing 
suppressed  
Airway resistance  Increases from wakefulness  Increases from 
wakefulness  
Body temperature Is regulated at lower set point 
than wakefulness; Shivering 
initiated at lower temperature 
than during wakefulness 
Is not regulated; no 
shivering or sweating; 
temperature drifts toward 







The circadian rhythm is a daily cycle of biological activity refers, collectively, to the daily 
rhythms in physiology and behaviour. This biological clock is based on a 24-hour period and 
influenced by regular variations in the environment, such as the alternation of night and day. 
The circadian rhythm controls the sleep-wake cycle, modulate physical activity and food 
consumption, and over the course of the day regulate body temperature, heart rate, muscle 
tone , and hormone secretion. The rhythms are generated by neural structures in the 
hypothalamus that function as a biological clock10.  
From Infancy to adulthood, there are significant and continuous changes in sleep 
architecture. This includes changes in how sleep is initiated and maintained, differences in 
the percentage of time spent in each stage during sleep and sleep efficiency (which means 
how successfully sleep is initiated and maintained)7. In general, sleep efficiency declines 
with age; New-borns sleep about 16 to 18 hours per day with short sleep episodes (2.5-4 
hours)11, 12. A new borne has three types of sleep: quiet sleep (similar to NREM), active sleep 
(similar to REM), and indeterminate sleep13. A baby in the second or third month starts to 
have a circadian rhythms which leads to sleep consolidation (longer times of wakefulness in 
the day and grater durations of sleep at night). By six months of age, a baby shows a slight 
reduction in the total sleep time with increase in the longest continuous sleep episode to 
nearly 6 hours 14, 15. A twelve months old sleeps about 14-15 hours per day; one to two naps 
during the day time but the majority of sleep consolidated in the night time14. Most children 




Young children appears to sleep less as a child gets older (two hours decrease from age 2 to 
age 5) with estimated sleep time of 11 hours per day at age 5.12. By the time a child enter 
school, a child begins to manifest circadian sleep phase preferences “ a tendency to be a 
“night owl” or “morning bird””15. 
 A complex and bidirectional relationship exists between pubertal development and sleep7. 
Adolescents need 9-10 hours of sleep each night16, 17. Pubertal and hormonal changes in the 
onset of the puberty influences sleep causing several changes; for instance the time spent in 
stage 2 increased 18, 19 . Greater daytime sleepiness in the midpuberty  and in the afternoon 
in more mature adolescents, besides decrease in total sleeping time and REM sleep with 
increasing age20.  
6 Sleep functions   
Important processes occur during sleep to preserve a healthy function of the brain and the 
body physical health. In brain, during sleep, new pathways to process new information are 
formed. Adequate sleep improves memory and learning, plays a role in attention and 
creativity, besides aids in making decisions21, 22. Insufficient sleep leads to functional 
changes in the brain and peripheral tissues in the body which alter the brain activity and the 
body function23. 
Sleep has a significant role in memory consolidation and selecting of important revived 
information throughout the day24. This process prioritises certain information and 
experiences due to an emotional or other connection 25 24.  In addition to memory 




channels in the brain to allow the flow of cerebrospinal fluid to clear the debris26. One 
example of these toxins is a protein associated with Alzheimer (Beta-amyloid protein)26. 
Sleep is important for maintenance of physical health, particularly healing and repairing of 
cells in body tissues23. Sleep helps regulating the hormones and minting their balance in the 
boday27, such as Growth hormone, Insulin which regulates Glucose levels in blood, and 
Ghrelin and Leptin which regulate feeling of hunger and fullness, thus there is a relation 
between sleep and growth and development, diabetes, obesity, and other conditions.27 
Furthermore, the immune system relies on sufficient sleep and the sleep quality; sleep 
deficiency  is related to increased risk of sickness difficulty resisting infections28.  
7 Sleep-disordered breathing 
Sleep-Disordered Breathing (SDB) is a term describing abnormal patterns of breathing 
present during sleep. SDB varies along a continuous spectrum according to the degree of 
obstruction from habitual snoring and Upper Airway Resistance Syndrome (UARS) to 
Obstructive Sleep Apnea (OSA)29. Partial airway obstruction manifests as habitual snoring 
or UARS, whilst complete upper airway obstruction manifests as OSA29. Obstructive sleep 
apnoea syndrome was first reported in children by Guilleminault in 1976. He described sleep 
apnoea symptoms in eight 5-14 years old children who showed similar polysomnographic 
characteristics as those seen in adults with sleep apnoea30. 
Habitual snoring is recognized by audible sonorous noises occurring more than three times 
per week without evidence of apnea, hypoventilation or significant sleep fragmentation.31 
Snoring occurs when there is an imbalance between negative intrathoracic pressure and the 




and/or partial obstruction of the upper airway during sleep, resulting in intermittent 
hypoxemia and hypercapnia, frequent arousals, and sleep fragmentation. A paediatric 
obstructive sleep apnea episode is defined as absence of airflow for two respiratory cycles 
(2 breaths) with continued chest wall and abdominal wall movement34, whereas an 
obstructive hypopnoea episode is defined as a decrease in nasal flow ≥30% (the drop should 
last at least 2 breaths from baseline) with a corresponding decrease of ≥3% in oxygen 
saturation and/or arousal34. 
7.1 Epidemiology 
In the past few decades, OSA has become widely recognized as a likely cause of 
considerable morbidity among children. Paediatric OSA differs from adult OSA in both 
clinical characteristics and determinants of its epidemiology35. Subdiagnosis, lack of 
community awareness about the negative sleep-related consequences on the daily 
functioning of children, and parents’ tendency to downplay the problem and not report it to 
their physician, all contribute to an underestimation of its prevalence and make it difficult to 
accurately determine prevalence figures36, 37. International studies report the prevalence of 
adult OSA to be within the range of 3 to 17% 38-41 with a higher prevalence reported recently 
in the “HypnoLaus” study42. In children, it varies from 0.7 to 24%, depending on the method 
used to diagnose OSA43-45. However, most authors report a prevalence of 10% for habitual 
snoring and 1.2 to 5.7% for OSA in children35, 45-48. In New Zealand, epidemiological studies 
show that OSA affects over 30% of the adult male population and over 9% of the adult 
female population, and that the prevalence of OSA in Māori ethnicity is approximately twice 
as high as that of non-Māori one49, 50. In a community sample of New Zealand children aged 




snoring has been reported to be significantly higher among 3-year-old children of Māori 
ethnicity52-54, but not in the smaller sample followed up at 7 years of age by Luo et al in 
201551. However, it seems that no study clearly indicates the prevalence of OSA in New 
Zealand children.  
7.2 Aetiology and pathophysiology of sleep-disordered breathing  
During sleep, OSA events occur through a complex interaction between sleep states, the 
mechanics of pressure and flow within the airway, and respiratory drive. Therefore, the 
aetiology of paediatric SDB is multifactorial55.  
Enlarged adenoids and tonsils are the most common cause of OSA in children. Paediatric 
OSA peaks in the preschool years as the lymphoid tissue is largest in relation to other 
structures of the upper airway56. Magnetic Resonance Imaging (MRI) studies have 
confirmed that the tonsils and adenoids of children with OSA are larger than in age-matched 
children who do not have OSA57, 58. Furthermore, the retro-palatal region has been suggested 
as the site of maximal upper airway obstruction, specifically, the overlap between the lower 
pole of the adenoids and the upper pole of the tonsils59. 
Other anatomical factors which affect the airway structure, causing upper airway collapse, 
have been identified as possible causes of SDB, such as: retrognathia, narrow maxillary 
dental arch, and smaller nasopharyngeal airway spaces. These features are consistently 
found to be associated with an increased incidence of OSA60, 61. It is not well known if the 
cephalometric features seen in OSA patients are the primary contributing cause of the 




congestion. A study supporting the latter suggestion reported favourable cephalometric 
changes in OSA children after adenotonsillectomy62.  
Several genetic and congenital syndromes are associated with SDB. These include 
syndromes with micrognathia in their clinical picture and those producing midfacial 
hypoplasia63. Syndromes in which craniofacial conditions affect the airways are summarised 
in (Table 2). 
Table 2 Craniofacial conditions associate with SDB63  
Syndrome or condition Features potentially affect airways and 
breathing (contributing to SDB) 
Craniofacial cleft  
(Pierre Robin, Stickler, Treacher Collins, 
Goldenhar, and Nager syndromes) 
 
Short mandible, retrognathia, and nasal 
deformity 
Micrognathia syndromes  
(Pierre Robin, Stickler syndromes) 
 
Micrognathia, glossoptosis, and midface 
hypoplasia 
Craniosynostosis 







Relative macroglossia, midface hypoplasia, 
reduced muscle tone 




  Approximately a quarter of all children are either overweight or obese64. It has been 
reported that childhood obesity increases the risk of developing OSA to the extent that, for 
every 1 kg/m2 increment in 
Body Mass Index (BMI) 
above the mean BMI for age 
and gender, there is a 12% 
increased risk of developing 
OSA55. Obesity contributes 
to OSA development by 
narrowing the upper airway 
due to fatty infiltration of 
upper airway structures, and 
because subcutaneous fat 
deposits in the anterior neck 
cervical region increase 
pharyngeal collapsibility65. 
In addition, the extra fat in 
the abdominal wall and 
cavity and in the thoracic wall acts to reduce the resting lung volume, resulting in a loss of 
caudal traction on the upper airway and an increase in pharyngeal collapsibility66. Figure (1) 
illustrates the pathophysiology and the consequences of paediatric OSA. 
 
Figure 1 Pathophysiology and consequences of 




7.3 Effects of body position and sleep state on OSA severity 
It has long been known in adults that obstructive respiratory events are at their most severe 
and frequent in the supine sleeping position67. This represents a striking feature so that more 
than half of all obstructive sleep apnea patients can be classified as having supine-related 
OSA67. Typically, the Apnoea Hypopnoea Index (AHI) is reported to be higher in supine 
sleep and to a lesser extent during REM sleep68. More recently, the relation between body 
position and OSA severity has been reported in children. However, paediatric studies 
showed a significant effect of body position on OSA severity although those findings are 
inconsistent as a study showed an improvement in OSA severity in supine position69; some 
studies reported a worsening of OSA in supine position70-72; and some others concluded no 
PSG positional difference in OSA children73-75. 
7.4 Consequences of obstructive sleep apnea 
Excessive daytime sleepiness, the most prominent clinical symptom of OSA in adults, is 
not a common complaint in paediatric SDB76. However, it is seen in some children with 
severe OSA and is more common in adolescents, particularly if they are morbidly obese77. 
In contrast, younger children often become hyperactive rather than sleepy29. 
Studies reported behavioural dysregulation as a common comorbidity of SDB in 
children78-82, such as inattention, hyperactivity, aggressiveness, and social withdrawal30, 83. 
There is good evidence that SDB leads to daytime disturbance, closely mimicking 
behavioural symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) 78, 84. 
Furthermore, a four-year prospective cohort study showed that SDB symptoms are 






Table 3 Cognitive and behavioural consequences of SDB 
Hyperactivity Hyperactivity is frequently reported in both children with habitual 
snoring as well as in SDB children formally diagnosed using 
polysomnography (PSG) 78, 79, 86-88.  
 
Inattention Inattentive behaviours identified by parental report have been observed 
in children with habitual snoring78, 80, 88, 89 and PSG-defined SDB90-93. 
ADHD Attention-Deficit Hyperactivity Disorder (ADHD) is one of the most 
frequently reported comorbidities in SDB children. The major features 
of ADHD are inattention, hyperactivity, and impulsivity. Conversely, 
comorbid sleep problems are highly prevalent in ADHD94. Sleep 
problems have been parentally reported in ADHD with a frequency up 




Large population-based studies reported that children with SDB 
symptoms were 20% to 100% as likely to have aggressive behaviours 
and other behavioural problems79, 82, which are similar to a study that 





Lower intelligence quotient (IQ) scores have been reported in children 
with SDB compared to controls, although these scores are typically still 




Several studies have reported that SDB children have deficits in 
academic performance. This includes lower grades in mathematics, 
spelling, reading and science89, 109-111. 
 
Executive function Executive function encompasses cognitive processes, such as planning, 
problem solving, and verbal reasoning. A recent study indicated that 
SDB children showed lower performance on executive function 
dimensions, such as inhibition, working memory, and planning 





In addition, learning problems and behavioural dysregulation can be commonly found in 
school-age children with SDB113. Thus, mild SDB without true OSA has often been shown 
to carry the same morbidity as OSA in children, including daytime somnolence, behavioural 
problems, and poor school and cognitive performance114. Table (3) summarises some of 
cognitive and behavioural consequences of SDB. 
In addition to daytime behaviour and neuro-cognitive disturbance, there is compelling 
evidence that SDB affects the quality of life in children86, 115. To evaluate quality of life in 
SDB children, survey instruments relying on proxy reports are used, such as the OSA-18 116, 
117.  
Nocturnal enuresis, in particular secondary enuresis, is associated with SDB in children118. 
It is thought that fragmentation of sleep architecture caused by apneic events and arousals 
may affect normal secretion of anti-diuretic hormone, and contribute to enuresis 
development. Nocturnal enuresis can be the principal clinical manifestation in some children 
with SDB118, 119.  
Obesity is not only considered a risk factor for SDB development, but can also be aggravated 
by OSA, thus is potentially a consequence of SDB. This concept arose from recent studies 
where OSA was found to promote weight gain via sleep fragmentation and associated 
daytime sleepiness, resulting in reduced daily physical activity120, 121. In addition, OSA 
exacerbates the magnitude of inflammatory responses, and is thus considered a risk factor 
for metabolic syndrome in children, which is a cluster of the most dangerous risk factors for 




Growth impairment is one of the main features in advanced paediatric OSA. SDB in 
children is accompanied by an abnormal secretion of growth hormone during sleep, and 
somatic growth impairment125. This in turn may affect craniofacial morphology, particularly 
the vertical features of the mandibular ramus62. Stunted growth in children with SDB could 
occur because of disturbance in growth hormone secretion from disruption in sleep 
architecture126. Hypertrophy of the tonsils can lead to difficulty in swallowing and interfere 
with adequate caloric intake, causing growth impairment. In addition, increased respiratory 
effort during sleep can drain the child’s caloric resources, which otherwise would be used in 
somatic growth29.  
The relationship between SDB and cardiovascular dysfunction in children has been 
recognised in the last few decades127, 128. This primarily manifests in elevated blood pressure 
and changes in cardiac structure and endothelial function129-131. Left ventricular hypertrophy 
has been described in children with SDB, and flow-mediated dilatation of the brachial artery 
is an indirect measure of endothelial dysfunction that is altered in SDB132. 
8 Diagnosis of obstructive sleep apnea 
Diagnosis of a child with suspected SDB requires clinical evaluation, by taking a thorough 
history of the child’s sleep patterns, parental observations of breathing during sleep, and 
daytime performance, in addition to a physical examination for the SDB risk factors, and 
finally, confirmation through objective assessment of sleep and breathing using 




8.1 Symptoms of OSA in children 
Symptoms of OSA can be classified into two categories: First, night time symptoms, which 
mainly include: habitual snoring, witnessed apneas and loud breathing, and frequent 
awakenings. Second, day time symptoms, which include: behavioural dysregulation (poor 
attention and hyperactivity), sleepiness, and mouth breathing45, 133-135. Table (4) 
demonstrates symptoms and signs of sleep disordered breathing in school age children (5-
15 years). 
Signs and symptoms of sleep-disordered breathing symptoms in children are different to 
those in adults. There are three main differences between adult and paediatric SDB patients. 
First, clinical presentation of SDB in children is more varied, and individual symptoms often 
lead to alternate diagnostic pathways, but consideration of a group of symptoms may help 
in defining SDB136. Second, unlike adults, excessive daytime sleepiness is not a major 
symptom of SDB in children, as only 7% present to a physician with excessive sleepiness 
during the day120. Rather, children tend to become hyperactive84. The third difference is that 
patients with paediatric SDB manifest different symptoms at different ages. However, some 
symptoms may present at any age, such as snoring and frequent arousals, while others are 
seen in certain age groups such as apparent life threatening events, poor day/night cycle, and 
breath holding spells in infants less than 12 months old; but in 1-5 year old children 
symptoms may include sleep terrors, daytime sleepiness, hyperactivity and inattention, and 
sleep in knee-chest position. In older age groups (between 5 to 18 years) we can see 






Table 4 School age (5-15 year) symptoms and signs of SDB6, 133, 136, 137 
Night time symptoms Day time symptoms Signs 
- Snoring 
- Witnessed apnoeas or labored 
breathing 
- Gasping/choking/snorting 
- Mouth breathing 







- Sleeptalking  
- Confusional arousal  
- Sleep walking 
- Difficulty waking up in morning  
- Drooling 
- Insomnia 
- Poor behaviour 
- Inattention at school or 
preschool 
- Hyperactivity 
- Mouth breathing 
- Learning difficulties 
- Excessive sleepiness 
- Morning headaches 
- Adenotonsillar hypertrophy 
- Micrognathia/retrognathia 
- Nasal inflammation and 
obstruction 
- Recurrent otitis media 
- Failure to thrive 
- Obesity 
- Hypertension 
- High-arched palate 
- Delayed puberty 
- Malocclusion (Class II or Class 
III), crossbite, crowded teeth  
- Mood disturbance, e.g.: 
depression, Delayed Sleep 
Phase Syndrome (DSPS) 
 
8.2 History and physical examination  
The clinical evaluation of children with suspected OSA involves taking a thorough history 
of the child’s sleep patterns and parental observations of breathing during sleep6. The extent 
to which the disorder is impacting on the functioning of the child in domains such as daytime 
performance and quality of life may also be assessed clinically. Physical examination should 
include: factors associated with a risk of OSA, such as tonsil size138, nasal inflammation and 




However, depending on clinical symptoms, identification and scoring of respiratory and 
arousal events to confirm OSA is not always reliable76, 140. 
Oropharyngeal examination is a significant part of SDB patient assessment. This 
examination can be used to prioritize children who may need further investigations to 
confirm OSA diagnosis136. Oropharyngeal examination includes Mallampati score and 
tonsillar size score. Mallampati score is a widely used subjective assessment of upper airway 
crowding, which involves visualization of the oropharynx with four classifications, shown 
in Figure (2)141. Tonsil size grading classifies tonsils into five grades from 0-4142. Those 
grades according to Friedman are illustrated in Figure (3)142. Assessment of tonsil size to 
predict OSA severity is controversial and it has been reported that there is no clear evidence 
about the value of this assessment in predicting SDB143. 
 
Figure 2 Mallampati classification of airway crowding141 
Class I (Tonsils, pillars and soft palate are distinctly visible)  
Class II (Tonsils, pillars and upper pole are visible)  
Class III (Only part of the soft palate is visible and the tonsils, pillars and base of the uvula 
cannot be seen)  







Obstructive sleep-related breathing disorder questionnaires were introduced to find simple 
and non-invasive tools to diagnose and evaluate children suspected of having OSA144. In 
1999, Chervin developed the Sleep-Related Breathing Disorder scale of the Paediatric Sleep 
Questionnaire (PSQ)145. This is a 22-question tool, which is filled in by parents and includes 
questions about history of breathing difficulties during sleep, snoring quality and frequency, 
daytime signs of sleepiness, inattention and hyperactivity, in addition to some other 
questions about morning headache, obesity, enuresis, and delayed growth145.  
Studies have consistently found that symptom scores are not reliable for OSA detection in 
snoring children76, 140. However, the PSQ yields sensitivity and specificity values of 85% 
and 87% respectively145, supporting the use of the questionnaire as an important screening 
tool, rather than a diagnostic one146. In general, two systematic reviews have concluded that 
signs and symptoms of OSA, either alone or in combination, do not satisfactorily predict 
 
Figure 3 grading scale of tonsil size142 
Grade 0: Tonsils absent 
Grade 1: Hidden behind tonsillar pillars 
Grade 2: Extend to pillars 
Grade 3: Visible beyond pillars 




paediatric patients with OSA33, 147. Polysomnography (PSG) continues to be the best 
diagnostic tool available for paediatric OSA, although it is time consuming, expensive, and 
often unavailable148. 
8.4 Video/Audio Recordings 
Analysis of snoring sounds has been proposed as a method of assessing breathing during 
sleep149. Use of audiotaping may be considered promising technique in establishing SDB 
diagnosis. Studies using these techniques have shown variability in their precision of 
predicting OSA, and therefore additional studies are required to confirm reliability150-152. 
Frequency domain analysis of snoring signals has also shown a promise in distinguishing 
OSA from Primary Snoring153. Acoustic analysis of snoring is relatively accurate, but it is 
not considered a strong method for diagnosing OSA and rigorous studies are needed to 
confirm its diagnostic value154.  
Videotaping can also yield a noninvasive measure of movement and therefore arousal155-157. 
Video recordings are also a useful adjunct to a comprehensive polysomnogram to evaluate 
body and head positioning, paradoxical movements, snoring, and mouth breathing. Studies 
correlating video scoring systems to standard polysomnography have been encouraging157, 
158. Future research will be necessary to validate the utility of a particular domiciliary 
video/audio study in a population with a well characterized symptomatology. 
8.5 Polysomnography (PSG) 
Formal confirmation of SDB diagnosis requires overnight polysomnography (PSG) for a 




parameters to assess disturbances in respiratory function and sleep architecture, and is thus 
considered the gold standard in diagnosis of SDB45, 159.  
The complete polysomnography is done in a specialized sleep laboratory and the following 
bioparameters are recorded: electroencephalography (EEG), chin electromyography (EMG), 
electrooculography (EOG), airflow, respiratory effort (measured by recording movements 
of the thorax and abdomen), pulse oximetry, and electrocardiography (ECG). Body position 
is also recorded and it is optional to record periodic leg movement. 
According to the American Sleep Disorders Association (ASDA) 160, 161, the methods of 
investigating OSA can be classified by the type of sleep study employed. See Table (5).  
Although in-lab polysomnography is considered the gold standard for the diagnosis of SDB, 
it is costly, involves a technically complex set-up, and scoring sleep stages is time-
consuming.162 Some authors reported that SDB is underdiagnosed because of lack of 
awareness about this syndrome among physicians and patients.This may due to the fact that 
SDB consequences are not specific to this condition and the clinical history alone is 
insufficient to diagnose OSA amongst children in the general population163. In addition to 
that, there are few sleep specialized laboratories around the world to confirm diagnosis in 
OSA suspected children164, 165. Consequently, in recent decades, there has been an increased 
interest in exploring cost-effective methods of diagnosing SDB, and greater attention has 
therefore been focused on abbreviated polysomnography using portable monitoring 
devices166, 167. 
The apnoea hypopnoea index (AHI) is the main metric used to indicate SDB severity 




be < 1 event/hour168-170. An AHI between 1-5 indicates mild OSA, an AHI <5 and ≤10 
indicates moderate OSA, and an AHI >10/hour is considered to be severe OSA171. 
Level 3 home polysomnography has been used in the majority of the published studies on 
home testing of SDB children. These abbreviated studies, using Level 3 PSG, are even 
performed in sleep laboratories in several European countries, as they are much less time 
consuming to set up and score159. 
Table 5 Polysomnography Levels160, 161, 167  
PSG sleep 
studies Level 
Bioparameters Number of 
bioparameters  
Requirements 
Level 1  
Full-night-in-
laboratory 
EEG, chin EMG, EOG, 
airflow, respiratory 
effort, pulse oximetry, 








through the night. 
Level 2  
Comprehensive 
in-home 
EEG, EMG, EOG, 
airflow, respiratory 
effort, pulse oximetry, 





professional is not 
required. 
Level 3  
Modified in-
home 
At least two 
bioparameters of 
respiratory movement, or 
respiratory movement 
and airflow, HR or ECG, 
pulse oximetry, 
monitoring can include 
EMG and body position 
can be established. 




professional is not 
required. 





recording                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
Airflow, pulse oximetry, 
or both. 
-One or two 
bioparameters. 
- Sometimes this type 





professional is not 
required. 
Abbreviations: electroencephalography (EEG), electromyography (EMG), 





8.6 Upper airway imaging modalities  
Several studies evaluated the utility of radiographs in addition to clinical examination in 
establishing the diagnosis of SDB, relying on the detection the anatomical features 
associated with SDB172, 173. Cephalometric and dental features in children with SDB are 
summarised in Table (6). A review of cephalometric studies form Marcus et al in 2012 
concluded that the presence of airway narrowing indicates an increased probability of 
detecting OSA by PSG45. Although related cephalometric studies did not assess sensitivity 
and specificity or positive and negative predictive values, measuring the ratio of tonsil width 
to the depth of the pharyngeal space on a lateral neck radiograph was reported to have good 
sensitivity and specificity (95.8% and 81.8% respectively) for distinguishing mild from 
moderate/severe OSA in a small number of patients138. Cephalometric-measured adenoidal 
enlargement was present in over 80% of SDB children and combining this measure with 
other SDB symptoms (mouth breathing or nocturnal enuresis) yielded more than 90% 
sensitivity in SDB diagnosis174.  
Direct visualization of the adenoids using nasopharyngoscopy is the diagnostic standard to 
evaluate adenotonsillar hypertrophy175, but neck radiographs may represent a valuable tool 
in a child who is difficult to examine, as adenoid hypertrophy evaluated by lateral radiograph 
correlates well with nasopharyngoscopy176. 
Rhinometry and pharyngometry may represent useful techniques in SDB diagnosis. Findings 
from a cohort study on children aged 8-11 years indicated that measuring the minimum 




technique for paediatric OSA.177 Another (uncontrolled) study showed that nasal resistance 
measured using rhinometry had a high sensitivity and specificity for predicting 
polysomnographic OSA178. This technique warrants further study and validation45.  
Table 6 Cephalometric and dental features of children with SDB  
Skeletal class II features  - Increased ANB angle (of less than 2º in comparison to 
control) in children with OSA and primary snoring 173, 
179  
- Retrognathic mandible179, 180  
 
Mandible - Retrognathic mandible180 
- Short mandibular plane length181 
- Steeper mandibular plane179 
 
Maxilla - A short maxilla (short nasal floor)180 
 
Facial height  - Increased posterior facial height180 
- Increased anterior lower facial height 180 
- Lower ratio of posterior/anterior total face height182 
 
A narrow pharyngeal 
airway 
space  
- There is strong support for reduced upper airway 
sagittal width in children with obstructive sleep 
apnea173, 179, 180 
 
Soft tissues - An anterior tongue base position180 
- A long soft palate180 
- Increased tonsil size138 
 
Dental features 
(Cephalometric & dental 
models) 
- Increased overjet183 
- Reduced overbite183 
- Class II molar relationship183 
- A large interincisal angle60  
-  Retroclined lower incisors60 
- Inclined occlusal plane179 
- Palatal cross bite182, 184 
- Deeper palatal height182 






Magnetic resonance imaging (MRI) of the upper airway in children with OSA compared to 
normal controls reveals a statistically smaller upper airway luminal volume and elongation 
of the soft palate, as well as enlarged tonsils and adenoids57. MRI studies are inconsistent 
regarding the anatomical features of children185. Although 3-dimensional studies of the 
upper airways and craniofacial morphology represents a valuable diagnostic tool, MRI is not 
indicated as a routine evaluation of SDB. However, MRI is reported to be a useful tool in 
identifying sites of obstruction, especially with persistent OSA in children186. 
8.7 Serum, urine and other breath-related biomarkers  
Paediatric OSA is associated with both systemic and localized inflammation of the upper 
airways. The association between OSA and systemic inflammation has been reported by 
studies showing up-regulation of plasma CRP187, 188, increased neutrophils in the sputum189, 
increased urinary levels of cysteinyl leukotrienes190, and increased levels of leukotrienes in 
addition to condensation of prostaglandins in exhaled breath in children with OSA191.  
Markers of local upper airway inflammation have also been identified in children with OSA: 
increased pro-inflammatory cytokines TNF-α, IL-6, IL-1α and increased T cells and 
decreased B cells in tonsillar tissue192, increased leukotriene receptor expression in tonsillar 
tissue193, increased cysteinyl leukotriene receptor expression in T cells from tonsillar tissue 
and upregulation of glucocorticoid receptors in adenotonsillar tissue194. 
9 Treatment of obstructive sleep apnea 




Continuous Positive Airway Pressure (CPAP) is a ventilator therapy delivered through a face 
mask, nasal mask or nasal pillows. Nasal CPAP was first introduced in 1981 as a treatment 
for adult OSA, to maintain the open upper airway by acting as a pneumatic splint195, with its 
first use in children with OSA was reported in 1986196.  
Nasal CPAP is effective in the treatment of both the symptoms and the polysomnographic 
evidence of OSA197. CPAP is advocated for severely affected adolescent SDB patients, or 
for persistent OSA after adenotonsillectomy 45. 
Not unlike adults, children’s adherence to CPAP treatment is a major obstacle to effective 
use. Studies report that the adherence to this type of treatment varies between 30-70% among 
treated children198, 199. From a biomechanical perspective, there are anecdotal reports of 
potential growth disturbances from long-term use of CPAP because the elastic strap which 
maintains the mask may apply a restraining force on the maxilla200. 
9.2 Adenotonsillectomy 
The first line and most common treatment for paediatric OSA is adenotonsillectomy, 
particularly for moderate to severe cases with adenotonsillar hypertrophy and no 
contraindication to surgery45. The incidence of adenotonsillectomy has increased in number 
in the past few decades and the indication for surgery has markedly shifted from recurrent 
infection to upper airway obstruction201, 202. 
Although significant improvements in AHI are observed following adenotonsillectomy, the 
cure rate of OSA after operation (defined as a post-adenotonsillectomy AHI 1 event/hour) 




Current studies report that adenotonsillectomy for children with SDB is associated with 
improvements in quality of life, behaviour, and cognitive function205. Moreover, the 
manifestation of enuresis can be reversed in 50% to 75% of the cases after 
adenotonsillectomy119, 206, 207. Increased GH secretion after adenotonsillectomy improves 
facial morphology in addition to other factors of achieving balance between tongue and 
cheek forces, and retrieval of nasal breathing62, 208. 
Evidence supported by meta-analysis reviews showed that OSA children with comorbid 
conditions of obesity and dentofacial abnormalities are strong candidate cases for persistent 
OSA after adenotonsillectomy209-211. 
Although the American Academy of Paediatrics recommends that clinicians reassess all 
patients with OSA for persisting signs and symptoms after adenotonsillectomy45, it is still 
uncommon (less than 5% of cases) to utilise postoperative polysomnography for children 
after adenotonsillectomy, and therefore, cases of persistent OSA are highly likely to be 
missed212, 213. 
Repeated adenoidectomy is sometimes required because it is associated with an increased 
risk of persistent OSA in comparison to adenotonsillectomy214, 215. 
Adenotonsillectomy is associated with a risk of postoperative complications, particularly 
respiratory compromise (defined as intermittent or continuous oxygen saturation of 70% or 
less, and/or hypercapnia, requiring intervention after surgery) 216, 217. Children with obesity, 
severe OSA, or craniofacial abnormality may require more protracted inpatient care and/or 




9.3 Medical treatment  
Two types of medications, which offer a therapeutic alternative to adenotonsillectomy have 
been studied in paediatric OSA: corticosteroids and leukotriene modifiers. 
Corticosteroids have been shown to reduce tonsillar proliferation in vitro, in tissue samples 
collected from children with OSA during adenotonsillectomy219. A reduction in the size of 
lymphoid tissues is expected due to anti-inflammatory and lympholytic effects of 
corticosteroids, but short course systemic administration of corticosteroids was found not to 
have a significant effect on adenoidal size or the severity of OSA220. However, topical 
corticosteroid, intranasal application, showed significant reduction in adenoidal size and 
snoring, as well as OSA severity221, 222. 
Leukotriene modifiers such as montelukast have been considered as a therapy option for 
children with mild OSA due to its anti-inflammatory properties. According to an RCT study, 
oral montelukast appears to be effective in improving respiratory disturbances in children 
with mild to moderate OSA, as demonstrated by improvements in AHI223, 224. 
A combination of intranasal corticosteroid and oral montelukast is considered a promising 
treatment and may provide an alternative to adenotonsillectomy in cases of mild paediatric 
OSA225. A recent study comparing anti-inflammatory drugs to adenotonsillectomy 
recommended surgical treatment as the first choice for children with moderate and severe 
OSA and confirmed the role of anti-inflammatory drugs in mild OSA cases226. 
10 Oral appliances in the treatment of obstructive sleep apnea 
A mutual interaction has been reported between the nasopharyngeal airway and the 




morphology and respiratory problems228, 229. Reciprocally, obstruction of the airways has an 
influence on the development of the stomatognathic system230, 231. 
A narrow upper airway, maxillary constriction and mandibular retrusion are thought to be 
common phenotypes of paediatric SDB180, 211, 232-234. After adenotonsillectomy, 
enhancement and acceleration of ramus and mandibular growth have been indicated further 
to normalisation of GH in paediatric OSA patients208, 235, but in many cases, growth 
acceleration was not sufficient to solve the already formed malocclusion. In turn, this 
requires further orthodontic treatment to solve the problem236. 
10.1 Oral appliances therapy mechanism of action and types 
Oral appliances have been widely used for the treatment of OSA, mainly in adults237-242. 
These appliances aim to increase the posterior oropharyngeal airway by reducing upper 
airway collapsibility during sleep137, and by triggering the stretch receptors, which in turn 
activate the airway supporting muscles28. Because of improved comfort, quietness, and 
portability, oral appliance treatment could potentially result in better patient adherence and 
acceptance than CPAP treatment239, 243, 244. 
The orthodontic interventions that have been introduced for treatment of paediatric SDB are: 
mandibular advancement splints (MAS), rapid maxillary expansion (RME), and facial 
mask245, 246.  
MAS is the most common type of oral appliance used in the treatment of SDB. Evidence 
supporting their use and efficacy in adults is increasing239, 247, but their use in children for 
SDB treatment is less common and they are usually designed as a functional appliance for 




growing patients may improve jaw skeletal and dentoalveolar relationships249-251, as well as 
increase nasopharyngeal airway dimensions 252, 253. Therefore, it may improve SDB 
symptoms237, 242, 243 on the basis of the significant relationship between paediatric OSA and 
craniofacial morphology172, 180, 254-256. 
RME is used when the patient has been diagnosed with a narrow upper jaw. RME decreases 
nasal resistance and allows tongue repositioning. As a result, it may reduce the risk of the 
obstruction that contributes to sleep apnoea257. The idea of using RME in SDB treatment 
arose when it was shown to decrease nocturnal enuresis in children258, which can be an 
associated symptom of SDB. RME caused a significant reduction in nocturnal enuresis in 
all treated cases259. RME is currently performed most often using a fixed intra-oral 
orthodontic appliance, which can be adjusted and worn at all times during the treatment. An 
expansion of 5 to 8 mm can be obtained over 30 days, with the expansion screw activated 
daily by parents (active phase); following this active phase, the expansion screw is locked 
into place for a retention phase of 2-6 months to allow re-calcification of the palatine suture 
(retention phase)260. 
Maxillary protraction devices may be considered as a treatment option, as the sagittal growth 
of the maxilla causes increases in the size of the upper airway245.  
10.2 Efficacy of Oral appliances therapy in paediatric OSA 
Both MAS and RME have the potential to become valuable alternative treatments for 
patients with known craniofacial risk factors for SDB, who are not candidates for 
adenotonsillectomy or who are unable to tolerate or are unaffected by first-line treatments; 




MAS might be an effective treatment for children with SDB244. They are relatively well 
tolerated by patients261, so they can easily be used for incremental advancement of the lower 
jaw262. MAS can also expand the upper arch263. They are suitable for both mixed and 
permanent dentitions263, and these appliances have low failure treatment rates261. The 
therapeutic rationale is that all orthodontic anomalies (except class III) benefit from 
mandibular advancement capable of enlarging the retrolingual space and at the same time 
promoting lingual advancement237.  
Although there is increasing evidence regarding the efficacy of MAS in adults with SDB, 
there is a paucity of information about their efficacy in children246, 264-266. The few studies 
carried out to date suffer from methodological flaws, including: heterogeneous samples, lack 
of randomization, limited power to detect a clinically relevant effect, and lack of an adequate 
control conditions, such as the use of a placebo-like appliance. A Cochrane review by 
Carvalho et al. (2007) showed that there is not enough evidence to affirm that oral appliances 
and functional orthopedic appliances are effective in the treatment of OSA in children266. 
This conclusion was supported by two recent systematic reviews and meta-analyses246, 
which confirmed that the current evidence is limited and suggested possible short-term 
effectiveness in paediatric OSA treatment265. Therefore, it is currently difficult to draw a 
conclusion regarding the possible efficacy of mandibular advancement appliances in 
children affected by SDB237, 242, 244, 267.  
To determine the cutoff point of successful treatment of OSA with an oral appliance, a 
decrease of 50% in AHI is considered appropriate in adults and was adopted in paediatric 
OSA research265. Table (7) summarises the four main studies on using mandibular 




Table 7 Summary of the published studies about mandibular advancement devices in children with SDB 
Study Villa et al., 2002237 Cozza et al., 2004242 Schutz et al., 2011268 Zhang et al., 2013269 
Study design RCT 
 
CCT CT CT 
Mean age  7.1±2.6 years 
 
5.91 years 
Range (4-8) years 
12.9 years ± 11.5 months 
9.7±1.5 years 
 
Participant number 32 (20males) 
-19  
-13 control  
 
20 OSA (10 males) 
  
20 control healthy? 
(10 males) 
- 16(treatment group) 
- No control  




16.2±3.4 18.7±1.8 18.1±1.04 
Follow up  6 months 6 months 12 months 10.8 months 
Attrition rate  28% 0.% 0% 0% 
Appliance & 
procedures 
Acrylic oral bite plate (positioning the 
mandible in its correct position in 
every patient as needed (advance 
receding mandible, raising deep bite, 
or recentering cross-bite)) 
Upper mandibular advancement splint 
with slow maxillary expansion to 
follow the maxillary transversal 
growth. A Tucat’s pearl was added to 
the splint, with a sliding wire for 
reference of the tip of the tongue and 
lower lingual arch soldered to bands 
on the primary molars 
 
Herbst appliance and maxillary 
expander  
Twin-Block, without maxillary 
expansion 
Outcomes -AHI reduction from 7.1±4.6 to 
2.6±2.2 
-AHI reduction from 7.8±1.8 to 
3.6±1.7 
- ESS reduction from 15.2±4.9 to 
7.1±2 
- significant reduction in respiratory 
disturbance index from 7.3±5.6 to 
1.3±1.8 (P0.05) 
- Significant reduction in AHI 
from 14.08±4.25 to 3.39±1.86 
(P<0.01) 
- significant increase in  oxygen 
saturation from 77.78±3.38 before 
treatment to 93.63±2.66 





10.3 Adherence to oral appliance treatment  
Studies using oral appliances for children with OSA reported that these appliances were well 
tolerated. A landmark study by Villa et al. (2002) reported a high dropout of 28% because of 
lack of tolerability and simple inconvenience at school237. 
Some available studies used new modifications of MAS appliances237, 242. On the other hand, 
some others used well known and commonly used mandibular advancement appliances such as 
Twin-Block and Herbst244, 268. Using new different designs may pose a challenge concerning 
children compliance and acceptance of those modified appliances, which are not tested in this 
regard. This was represented in high withdrawal rates in the Villa et al. (2002) study237. 
Adversely, when using Twin-Block as an example of commonly used and well accepted design, 
the attrition rate was 0% in one of the studies244.  
11 Adult SDB versus Paediatric SDB 
Paediatric OSA differs from adult OSA in both clinical characteristics and determinants of its 
epidemiology35. Consequently, diagnostic criteria and treatment protocols and methods differ 
from those in adults. Table (8) summarises the major differences between adult and paediatric 
OSA. More information about SDB in adults was reported in the New Zealand Dental 







Table 8 Summary of the differences between adult and paediatric OSA 
 Children Adults 
Sex distribution  Male: Female= 1:1 Male: Female= 8:1 
Weight  -Normal or underweight  
- Obesity increases the risk of 
developing OSA 
Commonly obese 
Snoring Continuous  Intermittent with pause 
Mouth breathing Common  Less common 
Chief complaint Snoring, difficult breathing  Daytime sleepiness 
Enlarged tonsils/adenoids Common  Uncommon 
Obstructive pattern Mostly apneas Mostly hypopneas  
State with most 
obstruction 
REM REM or non-REM  
Clinical arousal Uncommon  Common  
Sleep architecture Preserved  Fragmented  
Apnoea definition  absence of airflow for two 
respiratory cycles (2 breaths) 
with continued chest wall and 
abdominal wall movement34 
absence of airflow for at least 10 
seconds with continued chest wall 
and abdominal wall movement34 
Hypopnoea definition  decrease in nasal flow ≥30% (the 
drop should last at least 2 
breaths from baseline) with a 
corresponding decrease of ≥3% 
in oxygen saturation and/or 
arousal34 
decrease in nasal flow ≥30% (the 
drop should last at least 10 
seconds) with a corresponding 
decrease of ≥3% in oxygen 
saturation and/or arousal34 
OSA severity (AHI) - mild(AHI 1) 
- moderate (AHI =1-9) 
- severe(AHI ≥10) 
- mild(AHI =5-15) 
- moderate(AHI =16-30) 
- severe (AHI 30) 
Cephalometric features -small nasopharyngeal airway 
space45, 172 
- Class II skeletal tendency172, 271   
- Low position of the hyoid 
relative to the mandibular plane272 
- Class II skeletal tendency273 
Differential diagnosis Other causes of snoring or 
breathing difficulty during sleep 
Other causes of excessive 
sleepiness or sleep disruption 
Main sequelae Behavioural changes 
Neurocognitive deficits 
Daytime sleepiness  
Cardiovascular disease 
Primary treatment Adenotonsillectomy  CPAP therapy  
Surgical treatment  The most frequent surgical 
procedure is adenotonsillectomy 
The most frequent surgical 
procedures are 
Uvulopalatopharyngoplasty and 
other soft palate surgical 
techniques, maxillomandibular 
advancement, hyoid suspension, 
tracheostomy, and linguoplasty274. 
Oral appliance treatment  RME- MAS





12 Statement of the problem  
SDB can significantly affect children’s wellbeing, as it can cause growth disorders, educational 
and behavioural problems, and even life-threatening conditions, such as cardiorespiratory 
failure.  
Adenotonsillectomy represents the primary treatment for paediatric SDB where adeno-tonsillar 
hypertrophy is indicated. However, the invasive nature of this treatment with the risk of 
postoperative complications and reports of persistent OSA after the surgery encouraged 
researchers to look for alternatives especially for those with craniofacial anomalies, or for 
whom adenotonsillectomy or other treatment modalities have failed, or surgery is contra-
indicated.  
Mandibular advancement splints (MAS) may represent a viable treatment option. Whilst the 
efficacy of these appliances has been consistently demonstrated in adults, there is little 
information about their effectiveness in children. This raises the significance and importance of 
embarking on research to explore this field further and test the efficacy of MAS as an option or 
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2. Efficacy of a mandibular advancement appliance on 
sleep disordered breathing in children: a study protocol 
of a crossover randomised controlled trial 
Summary 
Background: Sleep-Disordered Breathing (SDB) varies from habitual snoring to partial or 
complete obstruction of the upper airway and can be found in up to 10% of children. SDB can 
significantly affect children’s wellbeing, as it can cause growth disorders, educational and 
behavioural problems, and even life-threatening conditions, such as cardiorespiratory failure. 
Adenotonsillectomy represents the primary treatment for paediatric SDB where adeno-tonsillar 
hypertrophy is indicated. For those with craniofacial anomalies, or for whom 
adenotonsillectomy or other treatment modalities have failed, or surgery is contra-indicated, 
mandibular advancement splints (MAS) may represent a viable treatment option. Whilst the 
efficacy of these appliances has been consistently demonstrated in adults, there is little 
information about their effectiveness in children. 
Aims: To determine the efficacy of mandibular advancement appliances for the management 
of SDB and related health problems in children.  
Methods/design: The study will be designed as a single-blind crossover randomized controlled 
trial with administration of both an ‘Active MAS’ (Twin-Block) and a ‘Sham MAS’. Eligible 
participants will be children aged 8 to 12 years whose parents report they snore ≥ 3 nights per 
week.  Sixteen children will enter the full study after confirming other inclusion criteria, 
particularly Skeletal class I or class II confirmed by lateral cephalometric radiograph. Each 
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child will be randomly assigned to either a treatment sequence starting with the Active or the 
Sham MAS. Participants will wear the appliances for three weeks separated by a two-week 
washout period. For each participant, home-based polysomnographic data will be collected four 
times; once before and once after each treatment period. The Apnoea Hypopnoea Index (AHI) 
will represent the main outcome variable. Secondary outcomes will include, snoring frequency, 
masseter muscle activity, sleep symptoms, quality of life, children behaviour, and nocturnal 
enuresis. In addition, blood samples will be collected to assess growth hormone changes. 
Trial registration: This study was registered in the Australian New Zealand Clinical Trials 
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1 Introduction 
The health impact of sleep-disordered breathing (SDB), particularly, obstructive sleep apnoea 
(OSA) has been increasingly recognized in both adults and children 1. The prevalence of OSA 
in children varies from 1 to 4% 2-4, while most authors report a 10% prevalence of habitual 
snoring in children 5. SDB has been associated with growth disorders 6, daytime sleepiness 7, 
educational and behavioural problems 8, 9, and nocturnal enuresis 10. In the most severe cases, 
OSA may have life-threatening consequences like cardiorespiratory failure, which can lead to 
death 11, 12.  
Enlarged adenoids and tonsils are the most common aetiology of OSA in children. Obesity 
during childhood represents another important risk factor for OSA 13, 14. Craniofacial anomalies 
are also associated with changes in airway morphology and respiratory problems 15. These 
anomalies, basically, include maxillary and mandibular retrognathia, increased facial height, 
decreased facial width, increased overjet, and palatal crossbite 16-23.  
Polysomnography (PSG) is considered the gold standard for SDB diagnosis, 1, and the apnoea 
hypopnoea index (AHI) is the main outcome to aid diagnosis. AHI is defined as the number of 
apnoea and hypopnoea events recorded per hour of sleep. A paediatric obstructive sleep apnoea 
event, relying on PSG, is defined as absence of airflow for two respiratory cycles (2 breaths) 
with continued chest wall and abdominal wall movement 24. Whereas obstructive hypopnea is 
defined as a decrease in nasal flow ≥ 30% (lasting at least 2 breaths) with a corresponding 
decrease in oxygen saturation ≥ 3% and/or arousal 24.  
Full PSG is costly to perform in sleep laboratory, and scoring sleep stages is time consuming 25 
. Consequently, over the last decades, there has been increased interest in cost-effective methods 
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of diagnosing SDB within the home setting using portable monitoring devices 26, 27. Type 3 
home PSG, also referred to as abbreviated PSG without electroencephalogram (EEG),  
electrooculogram (EOG) and electromyogram (EMG), has been used in the majority of the 
published studies on home testing of SDB in children; this abbreviated PSG, is more suitable 
for use in children, it is less time-consuming, and it is easier to set up and score 28. 
The first line and the most common treatment for paediatric OSA is adenotonsillectomy, 7, 29. 
Although significant improvements in the Apnea Hypopnea Index (AHI) are observed 
following adenotonsillectomy, full resolution of OSA (AHI≤ 1) occurs only in 27% to 60% of 
cases 30, 31. Adenotonsillectomy is also associated with risk of postoperative complications 
beyond the anaesthetic and surgical procedures. For example, OSA children show a 
significantly higher risk of respiratory compromise, defined as intermittent or continuous 
oxygen saturation of 70% or less, and/or hypercapnia, requiring intervention after surgery 32, 33. 
Children with obesity, severe OSA, or craniofacial abnormalities may require more protracted 
inpatient care and/or intensive care unit observation 34, 35. Studies have reported an accelerated 
mandibular ramus growth and improved facial morphology after adenotonsillectomy in 
paediatric OSA patients 36. This improvement may be due to normalization in growth hormone 
(GH) serum levels, also to a change of tongue and cheek posture 37. However, this growth 
acceleration is not sufficient to correct the malocclusion and the underlying skeletal discrepancy 
often requires subsequent dentofacial growth modification treatment 38. 
Continuous positive air pressure (CPAP) is the primary treatment option for adult OSA 1. CPAP 
is also advocated for severe paediatric SDB, or for persistent OSA after adenotonsillectomy, 
but it is generally not well tolerated by children 29. Adherence to CPAP treatment in children is 
a major problem, with rates of only 30-70% 39, 40. From a biomechanical stand-point, there are 
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anecdotal reports of potential facial growth disturbances from long-term use of CPAP due to 
the elastic strap which maintains the mask, as it may apply a restraining force on the growing 
maxilla 41. 
Oral appliances have also been widely used for the treatment of OSA, particularly in adults 1, 
42, 43. These appliances increase the posterior oropharyngeal airway and reduce upper airway 
collapsibility by holding the mandible in a protruded position during sleep; furthermore, the 
device may trigger stretch receptors, which in turn activate the airway supporting muscles 1. 
Previous studies have shown that oral appliances are better tolerated than CPAP treatment 43 
because of improved comfort, quietness, and portability. Mandibular advancement appliances 
are the most common type of oral appliances used in the treatment of SDB in adults, but their 
use in children is less common, with little information about their efficacy 43. The few studies 
on the subject suffer from important methodological flaws, making it difficult to reach a 
definitive conclusion about the efficacy of MAS appliances in children with SDB 42, 44-47.  
2 Objectives 
Aims of the study are: (1) to test the short-term efficacy of MAS in the treatment of children 
with SDB; and (2) to assess the effect of MAS treatment on quality of life, behaviour, growth 
hormone levels, and nocturnal enuresis in SDB children. 
3 Materials and methods 
3.1 Study design 
This study will be carried out as a single-blind crossover randomized controlled trial. Each 
participant will wear two appliances consisting of an active MAS and non-active MAS (Sham 
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MAS). Each appliance will be worn for a three-week treatment period, which will be separated 
by a two-week washout period. A similar study design and treatment time have been used in 
previous studies comparing the efficacy of MAS to nasal CPAP treatment in adults 48, 49. 
This study will be conducted in the Discipline of Orthodontics, School of Dentistry University 
of Otago, New Zealand. Ethical approval has been granted by the Human Ethics Committee at 
University of Otago [H14/054], and New Zealand Health Research South Ethics Committee- 
Southern District Health Board [01050]. The research has also been approved by Ngāi Tahu 
Research Consultation Committee (Research consultation with Māori).  
3.2 Participants 
3.2.1 Sample size estimation 
A reduction of 50% in AHI is generally considered clinically relevant 43. This change 
corresponds to a large effect size (Cohen’s d= 1.5). To detect this effect size, and setting α error 
to 0.05 and β error to 0.20 using a repeated-measurement design, we have estimated that at least 
13 participants are needed. We will recruit 16 children to account for possible dropouts. 
3.2.2 Recruitment 
We will advertise in local newspapers to invite children who live in Dunedin city/New Zealand, 
to participate in the study according to the following eligibility criteria: age 8-12 years; parental 
report of snoring three nights or more per week; A score for the Paediatric Sleep Questionnaire 
(PSQ) ≥ 0.3350. 
Exclusion criteria include severe OSA defined as an AHI >10 51; craniofacial syndromes and 
genetic syndromes; neuromuscular diseases; skeletal maxillomandibular  class III  confirmed 
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by lateral cephalometric radiograph (ANB angle) 52, 53.or  class III incisor relationships, or 
previous orthodontic treatment. 
Patients diagnosed with severe OSA will be referred to a Medical Specialist. 
3.3 Oral appliances 
An n-of-1 pilot study was undertaken to compare the acceptance, and the mechanical retention 
of different splint designs to choose the best design to be used in the main study. Four appliances 
were identified and tested in an eleven-year old boy with class II dental and skeletal jaw 
relationships, the appliances were: Traditional Twin-Block 54; Twin-Block with metallic 
fastener (TAP®-splint, SCHEU Dental Technology, Brussels, Belgium); Clear elastic Twin-
Block; Sham Twin-Block Figure (1). 
As discomfort affects adaptation and acceptance 55, 56, this was evaluated in a pilot study using 
two assessment methods: the participant was firstly asked to report how comfortable each 
appliance was immediately after insertion into the oral cavity in compare to the other 
appliances. The four appliances were presented in pairs to compare each appliance to the 
remaining three (a total of 12 pairs were generated to avoid confounding caused by sequence 
of appliances application); the participant was instructed to insert an appliance into the mouth 
and he was asked to move the mandible to the right and left, front and back, and then to swallow, 
then to repeat the same to another appliance; after that the participant was asked to indicate 
which of the two appliances was more comfortable to wear. The effect on speech was evaluated 
by asking the participant to count from 60 to 70 with each appliance inside the mouth, and 
comparing this with counting without the appliance in the mouth; the counting was audio 
recorded and assessed later by the researcher. The second method for evaluating discomfort 
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aimed to assess acceptance after wearing the appliance for two hours while awake and during 
one night sleep. One night appliance-free was allowed as washout period between two 
sequentially-tested appliances. Discomfort was assessed by using a 100-mm visual analogue 
scale (VAS) with words (worse than I can imagine; better than I can imagine) anchored at the 
left and right end of the scale, corresponding to worse discomfort and best comfort, 
respectively. The participant rated the discomfort intensity by putting a vertical slash on the line 
that best represented the intensity of discomfort. The higher the VAS score the better the 
appliance acceptance. Two separate VAS scores were collected after both the awake and asleep 
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Retention was tested using both a subjective and an objective assessment. Subjective 
assessment was made by asking the participant 1) if the appliance was held in the mouth the 
 
Figure 1 Appliances tested in a pilot study to identify the most suitable appliance 
design to be used in the main study 
A- Traditional Twin-Block: Removable upper and lower acrylic plates, each plate has 
matching pieces to encourage the lower jaw to slide forward, bilateral hooks were added 
to insert vertical elastics. 
B- Metallic fastener Twin-Block: Removable upper and lower vacuum formed plates and a 
metallic fastener (TAP) is used to hook the upper and the lower plates enabling the 
mandible to be advanced forward. 
C- Clear elastic Twin-Block: Removable upper and lower vacuum formed plates with 
matching pieces to encourage the lower jaw to slide forward, bilateral plastic hooks were 
added to accommodate vertical elastics. 
D- Sham Twin-Block: Removable upper and lower vacuum formed plates, without any 
lower jaw advancing device. 
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whole night, 2) if the upper and lower splints were fitting well to the teeth, and 3) if the upper 
and lower splints stay attached to each other. Response options were yes/no. 
Passive and active retention were also objectively tested by two independent examiners (GI, 
MF) by checking whether the appliance was stable in-mouth upon, 1) maximum jaw opening 
and, 2) direct pulling of the examiner.  
Results of the pilot study: 
Initial acceptance 
 Initial acceptance was based on the most accepted appliance. The following were used: 
(Sham appliance, traditional Twin-Block, Metallic Fastener Twin-Block, Clear elastic Twin-
Block) 
The traditional Twin-Block was the easiest appliance to remove as reported by the patient. 
This was because it was easy for the patient to find the clasps and take the splints out of the 
mouth. On the other hand, the Clear Elastic TB was the hardest one to remove out of the 
mouth because the patient had to take the appliance out by pushing the flange edges which 
extended high in the vestibule, taking care not to scratch the soft tissue..  
To observe retention of the appliances inside the mouth, the patient was asked to open their 
mouth to the maximum. The Traditional Twin-Block displayed the best retention followed by 
the metallic fastener Twin-Block. The Clear elastic Twin-Block was the worst for resisting the 
vertical elastic force and the appliance easily came off the upper and the lower arches. 
The sound recording assessment whereby the patient counted from 60 to 70 when wearing the 
appliance was compared to the recording when not wearing the appliance (reference). This 
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showed that the clearest pronunciation was found with the Sham Twin-Block, followed by the 
traditional Twin-Block, then the clear elastics Twin-Block, and finally use of the metallic 
fastener Twin-Block resulted in the worst speech pronunciation. 
Acceptance after use 
The patients rated the comfort of each appliance twice: during the day, and after waking up in 
the morning. These ratings showed that the Sham Twin-Block was the most comfortable 
MAS appliance followed by the traditional Twin-Block and then metallic fastener Twin-
Block. The least acceptable was the clear elastic Twin-Block. Results are presented in the 





Retention and stability inside the mouth 
 
Figure 2 Self-reported level of  discomfort after using the appliances in the 
pilot study: Self-reported comfort level during the day and night time using 
different appliance designs tested in the pilot study to identify the most suitable 




















Traditional TB Metalic Fastener TB Clear elastic TB Sham TB
Is the appliance comfortable?
Day time Night time
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 This was reported by the parents after their child going to deep sleep by answering the 
following questions: does the two splints stay link to each other; both splints stay stick to  
 
The upper and the lower arches; the appliance does not fall out the mouth during sleep. Table (1) 
The retention of the Twin-block VE and the Metallic Fastener TB was good. 
The vertical 1/8 Heavy elastic bands was good in keeping the upper and the lower splints 
together with the traditional design of the Twin-block. But they (the elastic bands) failed to do 
the same with the Clear Elastic TB (suck-down appliance). The metallic fastener was good in 
keeping the two splints together. 
There were significant differences among the appliances tested in the pilot study in  the level 
of discomfort reported by the patient considering the day and night scores when using each 
appliance for one night p= 0.001, Analysis of variance) 
Table 1 Retention and stability of the different appliances in the pilot study as reported 








Splints stay fitting together  Yes Yes No Yes 
Splints stay attached to the 
top and the lower teeth  
Yes Yes No Yes 
Splints fall out the mouth 
during sleep  
No No Yes No 
TB: Twin-Block 
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Since the traditional Twin-Block appliance showed the best retention and acceptance this was 
chosen as the study protocol intervention. Additional arguments in support of this decision 
were:  
 It is easy to titrate and can also be used to expand the upper arch57. 
 It includes metal clasps to increase retention as required57. 
 It is very popular amongst orthodontists and has been extensively tested in previous 
research58.  
 It has a low failure rate and is well tolerated by children 59. 
 It can be used for facial growth modification in patients with skeletal class II jaw 
relationship58. 
3.3.1 Twin-Block design (active MAS):  
This consists of two removable upper and lower plates; each plate has matching pieces which 
encourage the lower jaw to posture or slide forward as the teeth come together Figure (2) 54. 
Hooks will be added to the Twin-Block bilaterally to insert vertical elastics. These elastics will 
hold the mouth closed during sleep and the mandible postured in a forward position 60. The 
construction bite of the appliance will be determined using the George Gauge™ 61, which 
allows an accurate determination and registration of the mandibular advancement. The bite 
registration will be taken for all participants by advancing the mandible 75% of the maximum 
protruded position of the jaw with minimum bite opening.  
3.3.2 Sham MAS design (non-active MAS):  
This consists of two non-active upper and lower acrylic plates resembling the design of the 
active MAS, but without any component to protrude the mandible Figure (3). 
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Figure 3 Appliances to be used in the study 
A- Twin-Block appliance (active MAS) 
B- Sham MAS (non-active MAS) 
 
3.4 Randomisation  
Participants will be randomly assigned to either a sequence starting with the Twin-Block or the 
Sham MAS. Thereafter, participants will wear the appliances for three weeks separated by a 
two-week washout period. Participants will not be told whether they wear the active or the non-
active appliance. Each night of wear time will be recorded by parents using diaries.  
Patients will be allocated to active or sham treatment using four randomised n-of-4 blocks that 
are balanced for treatment sequence (Sequence 1: Twin-Block MAS first followed by Sham 
MAS; sequence 2: Sham MAS first followed by Twin-Block MAS) Figure (3). Allocation will 
be concealed in opaque envelopes, and disclosed by a member of the research team (MF) 
immediately after enrolment. Participant flow is illustrated in Figure (4)   
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Figure 4 Participants’ flow in the study 
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4 Outcome measurements and stepwise procedure 
4.1 Sleep data 
Home-based abbreviated polysomnography , (cardio-respiratory Level 3) 27, will be performed 
using a portable monitoring unit (Embletta MRP PG-XS-ENU, Natus Neurology Incorporated, 
Ontario, Canada).  
PSG recording channels in the Embletta unit will be comprised of one electromyographic 
(EMG) channel, a finger pulse oximetry, nasal airflow (using a nasal pressure catheter), nasal 
and mouth thermistry, thoracic and abdominal respiratory effort bands (two piezoelectric belts 
will be placed around the rib cage and abdomen and monitor respiratory movement), body 
position sensors, and a microphone attached to the nasal cannula extension. The following 
variables will be measured: pulse oximetry, airflow, respiratory effort, snoring sound, body 
position, and EMG of the masseter muscle. This equipment has previously been validated for 
the diagnosis and management of SDB 62-65. 
The portable device is set up through the use of a separate application software, RemLogic-E 
version 3.4 (Embla system, Natus Europe, Planegg, Germany). Channels are configured and 
identified, sampling rates set, filtering options defined, recording timing (on/off times), etc. 
through the same software. 
Home-based PSG data will be collected four times for each participant at baseline and after 
treatment with Twin-Block or Sham MAS, with the support of a research assistant Figure (5). 
The AHI will be calculated according to the American Academy of Sleep Medicine (AASM) 
criteria for scoring paediatric respiratory sleep studies 24. AHI is the main outcome of interest 
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and sleep position will be considered in AHI scoring because sleep related obstructive 
respiratory events in children occur more commonly in the supine sleep position 66. 
 
Figure 5 The study design is a crossover randomized controlled trial. Sixteen patients 
will be randomly assigned to two sequences; both sequences include a three-week treatment 
period with active and non-active (sham) mandibular advancement splints but in a different 
order (Active followed by Non-active and Non-active followed by Active) Treatment periods 
will be separated by a two-week washout period. Assessments will be taken at baseline (T0) and 
four times throughout the study. Abbreviations: Abbreviated polysomnography (PSG), 
Cephalograms (Ceph), Pediatric Sleep Questionnaire (PSQ), Behaviour Assessment System for 
Children, second edition (BASC-2), and Quality of Life questionnaire (OSA-18). 
 
4.2 Snoring frequency  
Snoring sounds will be assessed by analyzing audio recordings recorded using the portable PSG 
equipment. Snoring will be scored manually by listening to the audio recording using 
RemLogic-E software and the result will be reported as: total snoring time, relative snoring 
time, number of snoring episodes, average snoring episodes, and longest snoring episode. 
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The use of audio recordings is one of the recommended methods to aid visualise snoring 
oscillations 24. Embletta MPR microphone (an analogue omnidirectional condenser 
microphone) attached to nasal cannula will record the snoring sounds. All signals will be fed 
into analogue/digital (A/D) converter with a 200 Hz sampling rate (each channel has 200 points 
or samples per second) 67. For optimal visualisation of snoring, a high-pass filter to remove very 
low frequencies (20Hz) and a low-pass filter to remove high frequencies (3 kHz) will be used, 
this will permit acquiring relevant information of snoring sounds 68.  
Subjective reports of snoring frequency will also be collected by parents using daily diaries 
throughout each treatment period Figure (5).   
4.3 Growth hormone levels 
Blood samples will be taken from all participants by a certified phlebotomist in a medical 
laboratory (Southern Community Laboratories). Growth hormone will be indirectly assessed 
by determination of insulin-like growth factor-1 (IGF-1) levels 69. 
 
Two samples will be collected at the end of each treatment period and collected in a nonfasting 
state in the morning to early afternoon. IGF-1 concentrations will be assayed using a human 
IGF-I quantikine ELISA Kit (PDG100, R&D Systems, Minneapolis, USA). The human IGF-1 
immunoassay employs the quantitative sandwich enzyme technique.  Samples will be stored in 
a −80 °C freezer until batch assayed by a technician who will be blinded to the treatment period. 
Disposal of medical wastes will follow the World Health Organization guidelines 70, 71, and 
disposal with appropriate karakia (Māori prayer) will be offered to participant if needed.  
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4.4 SDB Questionnaire  
SDB associated symptoms will be assessed using the Pediatric Sleep Questionnaire and the 
Sleep Related Breathing Disorder (SRBD) subscale of the Paediatric Sleep Questionnaire 
(PSQ) 50. This 22-question tool will be filled in by parents and includes questions about history 
of breathing difficulties during sleep, snoring quality and frequency, daytime signs of 
sleepiness, Inattention and hyperactivity, in addition to a few other questions about morning 
headache, obesity, enuresis, and delayed growth. The optimal PSQ scale cut-off to indicate 
presence of SDB would be 0.33 (i.e. ≥ 33% of the 22 question-items answered positively)  50.  
 PSQ questionnaire will be administered four times during the study Figure (5). 
4.5 Quality of life 
The OSA-18 instrument is a quality-of-life questionnaire focusing on paediatric sleep 
disordered breathing. It has been used as a screening tool for paediatric OSA 75. This 
questionnaire consists of 18 questions grouped into five subscales: sleep disturbance, physical 
symptoms, emotional distress, daytime function, and caregiver concerns. The 18 survey items 
are scored using a 7-point scale, where the parent/caregiver is asked to report how often during 
the previous 2-3 weeks their child has had specific symptoms using the following response 
scale: (1) none of the time, (2) hardly any of the time, (3) a little of the time, (4) some of the 
time, (5) a good bit of the time, (6) most of the time and (7) all of the time. The total symptom 
score (TSS) may vary from 18 to 126 points. A TSS at or above 60 is considered abnormal and 
is associated with SDB. Scores of 60–80 suggest a moderate impact on the disease-specific 
quality of life and a score above 80 suggests a large impact  75.  
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OSA-18 questionnaire will be administered four times and parents/caregivers will rate the 
frequency of symptoms before and at the end of each treatment period Figure (5). 
4.6 Neurobehavioural assessment 
Behaviour will be assessed using the Behaviour Assessment System for Children: second 
edition (BASC-2). The BASC-2 tool has been widely used in studying behavioural differences 
in paediatric SDB patients 76. 
Parent Rating Scales (PRS) are used to measure both adaptive and maladaptive behaviours in 
the community and home setting. Parents or caregivers can complete forms at three age levels—
preschool (ages 2 to 5), child (ages 6 to 11), and adolescent (ages 12 to 21). The PRS contains 
134-160 items and uses a four-choice response format. Clinical and adaptive scales include the 
following domains: activities of daily living, adaptability, aggression, anxiety, attention 
problems, atypicality, conduct problems, depression, functional communication, hyperactivity, 
leadership, social skills, somatization, and withdrawal.  
It takes a parent approximately 10-20 minutes to complete this form and requires approximately 
a fourth-grade reading level for completion. Questionnaire for ages 6 to 11 will contains 160 
items; but the brief questionnaire of this scale consists of 30 items and will be used in our study. 
This questionnaire will be administered before and at the end of each treatment period Figure 
(5). 
4.7 Parent-report of nocturnal enuresis 
As about 24% of children with sleep apnea have nocturnal enuresis 77, urine incontinence will 
be assessed during the study by parents/caregivers using diaries in both treatment periods to 
report frequency of enuresis. 
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4.8 Sleep study scoring  
A certified sleep technologist will manually score all PSG data to determine the AHI according 
to the AASM criteria 24. PSG scoring will be performed using a special software RemLogic-E 
version 3.4 (Embla system, Natus Europe, Planegg, Germany). The scorer will be blinded to 
the patients’ information and to any indication of the treatment period and appliance used, 
moreover the technologist will have no contact with the participants through the study progress. 
To test reliability of scoring PSG data, ten PSG recordings will be chosen randomly and re-
scored by the same sleep technician to detect intra-rater reliability.  
4.9 Statistics 
Data will be analysed by SPSS (SPSS, IBM Corp. Version 22.0. Armonk, NY, USA) to perform 
descriptive statistics, and a mixed model analysis, and Bonferroni corrected post-hoc tests as 
appropriate. The significance level will be set at P = 0.05. 
5 Anticipated results 
Early treatment of SDB in children is vital to prevent significant health issues that may develop 
later. Therefore, SDB may have a significant impact on the wellbeing of many children. With 
a significant number of cases having persistent OSA after adenotonsillectomy or failure to 
tolerate CPAP treatment, it is worth exploring alternative options to the current advocated 
treatment modalities. The MAS intervention may be a valuable and effective alternative for 
patients who have known craniofacial risk factors of SDB, are on long waiting lists for 
adenotonsillectomy, are not suitable candidates for adenotonsillectomy, or are not able to 
tolerate or failed either first-line treatments, such as adenotonsillectomy or CPAP 47. 
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MAS may be particularly suitable for children with SDB, because it is relatively well tolerated 
and can be easily titrated to obtain an incremental advancement of the lower jaw 78. MAS can 
also expand the upper arch 54, is suitable for both mixed and permanent dentitions54,  and has a 
low failure rate 59 . The therapeutic rationale is that the majority of orthodontic anomalies 
(except class III-protruded mandible), benefit from mandibular advancement capable of 
enlarging the retrolingual space and at the same time promotes lingual advancement 42.  
 
Although there is increasing evidence regarding the efficacy of MAS in adults with SDB, there 
is a paucity of information about their efficacy in children 46, 47, 79, 80. The few studies carried 
out to date suffer from methodological flaws including: heterogeneous samples; lack of 
randomization; limited power to detect a clinically relevant effect; and lack of an adequate 
control conditions such as the use of a placebo-like appliance. A Cochrane review 79 has 
concluded that there is not enough evidence to support the efficacy of oral appliances and 
functional orthopedic appliances for the treatment of OSA in children. This conclusion was also 
reached by two recent systematic reviews and a meta-analysis which confirmed that the current 
evidence is limited, but suggests possible short-term effectiveness for treating paediatric OSA 
46, 47. Therefore it is currently difficult to draw a conclusion regarding the possible efficacy of 
mandibular advancement appliances in children affected with SDB 42, 44, 45, 81, and there is a 
strong need to carry out well-designed RCTs.  
Cross over RCT design has been widely used in studying efficacy of oral appliances with 
obstructive sleep apnea patients 80. Potential advantages of the crossover design that will be 
used in current study are its robustness and simplicity of application. Despite these advantages, 
the current study protocol will have some limitations as it depends on short-term evaluation (3 
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weeks for each treatment period), and the study will rely on subjective assessment of several 
secondary outcomes by using questionnaires in evaluating these measures by 
parents/caregivers. In addition to the possibility of having limited power regarding the 
secondary outcomes because the sample size estimation was assessed only relying on the main 
outcome (AHI). However the study will serve to provide descriptors of these, useful for 
planning further research in the field. 
Randomised clinical trials represent the gold standard for the evaluation of therapeutic 
effectiveness 82 therefore, unlike the previous studies, it is expected the current study protocol 
will provide new robust and reliable information about the possible efficacy of MAS for the 
management of SDB in children. The crossover design will allow each participant to act as 
his/her own control, thus increasing the power of the study. This study will also systematically 
address efficacy of MAS on other important health outcomes related to SDB, such as quality of 
life, neurobehavioural functioning and growth hormone changes; outcomes that have not been 
widely addressed in previous intervention studies investigating pediatric snoring or OSA 47. 
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3. Efficacy of a mandibular advancement appliance on 
sleep disordered breathing in children: a crossover 
randomised controlled trial 
Abstract 
Study objective: The objective of this study was to test the efficacy of a mandibular 
advancement appliance (MAS) for the management of Sleep-Disordered Breathing 
(SDB) and associated symptoms in children.  
Methods: The study was carried out as a single-blind crossover randomised controlled 
trial (RCT) with administration of both an Active and a Sham MAS. Eighteen children 
were recruited in the trial and randomly assigned to a treatment sequence, starting with 
either the Active or the Sham MAS. Participants wore the appliances for three weeks, 
separated by a two-week washout period. For each participant, home-based abbreviated 
polysomnographic data (cardio-respiratory Level 3) were collected four times before and 
at the last night of each treatment period. The apnoea hypopnea index (AHI) and snoring 
frequency (snoring time and number of snoring episodes) were assessed as the main 
outcome variables. Secondary outcomes included serum levels of Insulin-like Growth 
Factor 1 (IGF-1), obstructive sleep-related breathing symptoms, as assessed by the 
Paediatric Sleep Questionnaire (PSQ), quality of life, as assessed by the OSA-18 
questionnaire, and childhood behaviour, as assessed by the Behavioural Assessment 
System for Children (BASC-2) Behavioural and Emotional Screening System (BESS). 
Results: Compared to a Sham MAS, wearing an Active MAS resulted in a significant 
reduction in AHI of 40% (p=0.002). The separate assessment of AHI in supine and non-
supine sleeping positions revealed that only the former was significantly influenced by 





time per night was 46.3 minutes shorter with the Twin-Block than with the Sham 
appliance (95% CI=14.5-78.1; p=0.004).  
Compared to a Sham MAS, the Active MAS also reduced SDB symptoms, as represented 
by PSQ, OSA-18, and BASC-2 scores (P≤0.028). IGF-1 levels, however, did not differ 
between the two treatment periods (P=0.172). 
Conclusion: Within the limitations of this study, it can be concluded that wearing a 
mandibular advancement splint over a short period can be beneficial for children affected 







Sleep disordered breathing (SDB) encompasses a continuous spectrum of disorders, 
ranging from habitual snoring to obstructive sleep apnoea (OSA), which are depending 
on the degree of upper airway obstruction. The health impact of SDB has become 
increasingly recognised in children1, 2, 3. The prevalence of OSA in children ranges from 
1 to 4%2, 4, 5, while most authors report a 10% prevalence of habitual snoring in children6. 
SDB has been associated with growth disorders, daytime sleepiness7, educational and 
behavioural problems8, and nocturnal enuresis9. In the most severe cases, OSA may have 
life-threatening consequences, such as cardiorespiratory failure1, 7.  
Oral appliances have also been widely used for the treatment of OSA in selected patients1, 
10, 11. These appliances increase posterior oropharyngeal airway and reduce upper airway 
collapsibility by holding the mandible in a protruded position during sleep. Furthermore, 
the appliance may trigger stretch receptors, which in turn activate the airway supporting 
muscles1 increasing airway patency.  
Previous studies have shown that oral appliances are better tolerated than continuous 
positive air pressure (CPAP), which is currently considered the first-line treatment option 
for adult OSA, due to improved comfort, quietness, and portability1, 11. Mandibular 
advancement splints (MAS) are the most widely used oral appliance for treating SDB in 
adults, but their use in children is less common, and there is little information about their 
efficacy11-15. To date, there are only a few studies testing the efficacy of MAS in children, 
which suffer from methodological flaws, including: heterogeneous samples, lack of 
randomisation, limited power to detect a clinically relevant effect, and lack of adequate 
control conditions, such as the use of a placebo-like or sham appliance. One Cochrane 





appliances and functional orthopaedic appliances for the treatment of OSA in children. 
This conclusion was also reached by two recent systematic reviews and a meta-analysis, 
which confirmed that the current evidence is limited, but suggests possible effectiveness 
of MAS for treating paediatric OSA12, 13. Therefore, it is currently difficult to draw a 
conclusion regarding the efficacy of mandibular advancement appliances in children 
affected with SDB10, 16-18, and there is a strong need to carry out well-designed RCTs. 
2 Objectives 
The aims of this study were: (1) to test the short-term efficacy of MAS in the treatment 
of children with SDB, and (2) to assess the effect of MAS treatment on quality of life, 
behaviour, and growth hormone levels. 
3 Methods 
3.1 Study design 
This study was carried out as a single-blind crossover randomised control trial. Each 
participant wore two appliances, consisting of an Active and a Sham MAS. Each 
appliance was worn for a three-week treatment period. The first and second treatment 









3.2 Participants and setting  
This study took place between May 2014 and December 2015, and was conducted at the 
Discipline of Orthodontics, School of Dentistry, University of Otago, Dunedin, New 
Zealand. Ethical approval was granted by the University of Otago Human Ethics 
Committee [H14/054], and Health Research South Ethics Committee - Southern District 
Health Board [01050]. The research protocol was submitted to the Ngāi Tahu (Māori) 
Research Consultation Committee, and was considered of importance to Māori health. 
The trial was registered in the Australian New Zealand Clinical Trials Registry 
(ACTRN12614001013651). The full protocol has been published 19. 
 
 
Figure 1 Study design 
The study was designed as a crossover randomised control trial, with participants 
serving as their own controls. Participants were randomly assigned to one of two 
sequences. Both sequences included two three-week treatment periods, where the 
participant had to wear either an active or a sham mandibular advancement splint. The 
order of splint delivery differed between sequences (active splint followed by sham 
splint, and vice-versa). The first and second treatment periods were separated by a 





3.2.1 Sample size estimation 
A reduction of 50% in AHI is generally considered clinically relevant in previous study 
which used oral appliances in paediatric OSA 10, 18. Sample size was determined using 
previous estimates of AHI variability in children18 by setting α error to 0.05 and β error 
to 0.20 using a repeated-measurement design. We estimated that at least 13 participants 
would be needed. We aimed to recruit additional children to account for any possible 
dropouts. 
3.2.2 Recruitment 
Advertisements were placed in local newspapers and on community noticeboards to 
invite children who snore regularly and loudly, were 8-12 years old, and lived in 
Dunedin, New Zealand to participate in the study. 
Thirty-one parents contacted the research team with expressions of interest, and were 
sent information sheets by mail. Twenty-two respondents presented to the Dental School 
for a clinical screening, and their parents were asked to complete the Paediatric Sleep 
Questionnaire (PSQ). Individual height and weight measurements were taken at the first 
appointment to calculate the body mass index (BMI), and an oral examination was 
performed. Tonsil size and oropharyngeal patency were visually inspected and scored 
according to Mallampati20. Dental impressions were taken using alginate impression 
material (Orthotrace, Cavex Holland BV, Haarlem, The Netherlands), and poured with 
stone (Ortho Stone & Ortho Plaster, Nobilium Company, New York, USA) to obtain 
study and work models. Additional records that were collected included intra-oral and 
extra-oral photographs and lateral cephalograms in the maximum intercuspal position 
(Carnex Tome Ceph, SOREDEX, Tuusula, Finland). The cephalometric landmarks and 





Figure 2 Cephalometric landmarks and measurements used to describe the 
dentofacial features of participants enrolled in the trial. 
 
 
1- SNA (deg) the angle formed by the planes sella-nasion and nasion-point A 
2- SNB (deg) the angle formed by the planes sella-nasion and nasion-point B 
3- ANB (deg) the angle formed by the planes nasion-point A and nasion-point B 
4- Wits appraisal (mm) distance between the projection of points A and B on the 
occlusal plane 
5- SN-MP (deg) the angle between the mandibular plane and sella-nasion 
6- MMPA (deg) the angle formed between the palatal (ANS-PNS) and 
mandibular planes 
7- Lower face height (LFH) (ANS-Me) (mm) measured by the distance from 
ANS to menton 
8- Total face height (TFH) (N-Me) (mm) measured by the distance from N to 
menton 
9- UIA the angle formed by the long axis of the upper incisor and the maxillary 
plane 
10- LIA the angle formed by the long axis of the lower incisor and the mandibular 
plane 
11- Li-APog (mm) distance between the tip of the lower incisor (Li) and (A-Pog)  
12- Interincisal angle (deg) the angle formed by the long axis of the upper and 
lower incisor  
13- Upper lip relation to Ricketts E line (mm) measured by the distance between 
labrale superius (Ls) to Ricketts E line  
14- Lower lip relation to E line (mm) measured by the distance between labrale 





Eligible patients had to meet the following inclusion criteria: an age range from 8 to 12 
years, and a parental report of heavy snoring for three or more nights per week. 
Exclusion criteria were: previous orthodontic treatment, craniofacial and genetic 
syndromes (e.g. cleft lip and/or palate), neuromuscular disorders, and Class III incisor 
and/or skeletal relationship, as confirmed by lateral cephalometric radiograph (ANB 
angle ≤ 0 degrees)21. 
Eighteen participants met these criteria, and were enrolled in the study after signing a 
written informed consent. 
3.3 Oral appliances 
The performance of different MAS designs in terms of retention and comfort was tested 
in a pilot study (see Chapter 2 for details). Since Clark’s Twin-Block22 was ranked as the 
most retentive and best tolerated appliance, it was chosen as the active intervention for 
this RCT. Treatment was provided by a member of the research team (GI). 
3.3.1 Twin-Block design 
This consisted of two removable upper and lower acrylic plates, each with matching 
surfaces, which encourage the lower jaw to posture forward as the upper and lower teeth 
come together Figure (3A)23. Bilateral hooks were added to the appliance in order to 
insert vertical elastics. The purpose of these elastics was to hold the mouth closed during 
sleep, and to keep the mandible in a forward position24. A construction bite was taken of 
the appliance, using a commercial device25 (George Gauge™, Scheu Dental Technology, 
Brussels, Belgium). For all participants, the bite registration was taken by advancing the 





3.3.2 Sham MAS design  
This consisted of two upper and lower acrylic plates, resembling the design of the active 
MAS, but without any component to protrude the mandible Figure (3B). 
 
Figure 3 Appliances used in the study: the Twin-Block appliance (A) consisted of 
removable upper and lower acrylic plates, which hold the mandible in the forward 
position with interlocking blocks. The bite registration was taken by advancing the 
mandible to 75% of the maximum jaw protrusion, with minimum bite opening. To 
keep the mandible in this position during sleep, bilateral hooks were added to the 
appliance in order to insert vertical elastics. The Sham appliance (B) consisted of a 









3.4 Outcome measurements and procedure 
Primary Outcomes 
3.4.1 Apnoea-hypopnoea index and snoring frequency 
Level 3 home-based abbreviated polysomnography (cardio-respiratory) 29 data were 
collected using two portable sleep monitoring units (Embletta MRP PG-XS-ENU, Natus 
Neurology Incorporated, Ontario, Canada). The monitoring unit allows the recording of 
the following data: finger pulse oximetry, nasal flow (nasal cannula connected to a 
pressure transducer in the recording unit), nasal and mouth thermistry, thoracic and 
abdominal respiratory effort (using two piezoelectric belts that were placed around the 
rib cage and abdomen to monitor respiratory movement), electromyography (EMG), 
gravity, activity, and sound amplitude recorded by a microphone attached to the nasal 
cannula extension. For the purpose of the present study, the following variables were 
assessed: pulse oximetry, nasal and oral pressure/airflow, respiratory effort, and snoring 
sounds. This equipment has previously been validated for the diagnosis of SDB30-33. 
EMG activity from the masseter muscles was also collected however EMG data are not 
presented in this report. The superficial head of the masseter muscle (right side) was 
located by palpation after asking the child to clench his/her teeth. The bipolar EMG 
electrodes were placed on the masseter muscle position spaced approximately 6 cm apart, 
and a monopolar ground electrode was placed on the mastoid on the same side,  
The portable unit and the recording time (on/off times) were set by software (RemLogic-
E version 3.4, Embla system, Natus Europe, Planegg, Germany). PSG signals were 
acquired at 24-bit resolution and sampled up to 8000 Hz (snoring sounds). Nasal pressure 
was sampled at 250 Hz, whereas the effort signals recorded by inductance bands were 





For each participant, home-based PSG data were collected four times before and after 
each treatment period with the Twin-Block or the Sham. The sleep studies were carried 
out with the support of a research assistant, who was experienced in sleep research.  
The AHI scoring also included sleep position, because sleep related obstructive 
respiratory events in children are more common in the supine sleep position34. The AHI 
was calculated according to the American Academy of Sleep Medicine (AASM) criteria 
for scoring paediatric respiratory sleep studies35.  
Snoring was assessed by audio recordings, which is one of the recommended methods to 
aid visualising snoring oscillations35. The Embletta MPR microphone used to record 
snoring is an analogue omnidirectional condenser microphone, which was attached to the 
nasal cannula. For optimal visualisation of snoring, a high-pass filter was used to remove 
very low frequencies (20Hz), and a low-pass filter to remove high frequencies (3 kHz). 
This allowed researchers to acquire relevant information on the sound of snoring36.  
Subjective reports of snoring frequency and wearing of appliances (i.e. treatment 
adherence) were recorded in diaries, to be filled in by parents every night throughout 
each treatment period. Snoring was scored as a polychotomous variable (yes, no, don’t 
know), while wearing of appliances was scored as a dichotomous variable (full-night, 
less than full-night). 
3.4.2 Sleep study scoring  
Recorded data from the Level 3 Sleep Studies was analysed automatically using custom 
RemLogic-E software (version 3.4, Embla system, Natus Europe, Planegg, Germany). 
Respiratory events and snoring periods were then manually edited over generally 2 
minute epochs by a registered respiratory/sleep physiologist. The sleep physiologist was 





obstructive apnoea was defined as a decrease ≥ 90% of the pre event baseline measured 
by thermistor or a valid alternative sensor (nasal pressure sensor) for at least 2 breaths 
and associated with continued respiratory effort35. An hypopnoea was defined as a 
decrease ≥ 30% from pre event baseline measured by nasal pressure sensor, lasting at 
least 2 breaths with a corresponding decrease in oxygen saturation ≥ 3% or arousal 
indicated by surrogate measures including movement measured by actigraphy, changes 
in snoring sounds, >10% increase in heart rate or abrupt changes in thoracoabdominal 
effort37. A central apnoea was defined as a decrease ≥ 90% of the pre event baseline 
measured by thermistor or a valid alternative sensor, lasting 20 seconds or at least the 
duration of 2 breaths and associated with a ≥ 3% oxygen desaturation or arousal indicated 
by surrogate measures as above, or lasts at least the duration of 2 breaths and is associated 
with a decrease in heart rate to <50 BPM for 5 seconds. The apnoeas are associated with 
absence of inspiratory effort.  A mixed apnoea was defined if it met the 2 breath apnoea 
criteria and was associated with absence of effort during one portion of the event and the 
presence of inspiratory effort in another portion38. Snoring was scored manually by 
listening to the recordings in synchrony with the respiratory variables. Snoring events 
were tagged on the recorded audio graph. The occurrence of snoring was assessed as total 
snoring time per night and the number of snoring episodes over the entire duration of the 
recorded sleep period. 
To test intra-examiner reliability of AHI scoring, ten PSG recordings were chosen 
randomly, and AHI was re-scored by the same sleep physiologist one month after the 






3.4.3 Growth hormone levels 
Blood samples were taken from all participants by a certified phlebotomist in a 
specialised laboratory (Southern Community Laboratories, Dunedin, New Zealand). 
Growth hormone levels were indirectly assessed by determining the levels of insulin-like 
growth factor-1 (IGF-1)39. 
Two samples were collected from each participant in a non-fasting state at the end of 
each treatment period in the morning to early afternoon. IGF-1 concentrations were 
assayed using a human IGF-1 Quantikine ELISA Kit (PDG100, R&D Systems, 
Minneapolis, USA). The human IGF-1 immunoassay employs the quantitative sandwich 
enzyme technique40. Samples were stored in a freezer at -80°C until batch assayed by a 
technician who will be blinded to the treatment period. Disposal of medical wastes 
followed the World Health Organisation guidelines41, 42, and disposal with appropriate 
Karakia (Māori prayers) were offered to participants on request.  
3.4.4 SDB questionnaire   
SDB associated symptoms were assessed using the sleep related breathing disorder 
Paediatric Sleep Questionnaire (PSQ)43. The PSQ cut-off to indicate the presence of SDB 
is 0.33 (i.e. positive answers on ≥ 33% of the 22 question items)43.  
The questionnaire was completed by parents/caregivers. PSQ and ESS questionnaires 
were administered four times during the study, before and after each treatment period. 
Further information about this questionnaire is available in Chapter 2, and a copy of the 





3.4.5 Quality of life 
The OSA-18 instrument is a quality-of-life questionnaire with a focus on paediatric sleep 
disordered breathing. It has been used as a screening tool for paediatric OSA51. This 
questionnaire consists of 18 questions about sleep and respiratory disturbance, as well as 
other symptoms caused by OSA. The total symptom score (TSS) resulting from this 
questionnaire may vary from 18 to 126 points. A TSS at or above 60 is considered 
abnormal, and is associated with SDB. Scores of 60–80 suggest a moderate impact on 
the disease-specific quality of life, and a score above 80 suggests a large impact51.  
The OSA-18 questionnaire was administered four times, and parents/caregivers rated the 
frequency of symptoms before and at the end of each treatment period. 
3.4.6 Neurobehavioural assessment 
The Behavioural and Emotional Screening System (BESS)52 is a recently developed set 
of measures consisting of brief (30 items) derived from the Behaviour Assessment 
System for Children, Second Edition (BASC-2)53. This BASC-2 tool has been widely 
used in studying behavioural differences in paediatric SDB patients53. The shorter BESS 
questionnaire is designed to quickly screen children and adolescents from preschool to 
high school for current or future emotional or behavioural problems. Parent rating scales 
from questionnaires validated for use in 6-11 year old children were used to measure 
both adaptive and maladaptive behaviours in the community and home setting. The 
BASC-2 BESS 52was administered before and at the end of each treatment period. A T 
Score was calculated for BASC-BESS. The T score is a score derived from the total raw 
score of the questionnaire (30 questions) to adjust for the gender (male, female) and age 





3.4.7 Parent report of nocturnal enuresis 
Since around 24% of children with sleep apnoea report nocturnal enuresis54, the 
frequency of bed-wetting was recorded by parents/caregivers using written diaries 
(yes/no question), and completed throughout the study period. 
3.5 Randomisation  
Participants enrolled in the trial were randomly assigned to one of two different 
sequences. During sequence # 1, the Twin-Block MAS treatment was delivered first, and 
was followed by the Sham MAS. In sequence # 2, the Sham MAS was delivered first, 
and was followed by treatment with the Twin-Block MAS. 
Randomisation was performed using computer-generated n-of-4 blocks, which were 
balanced for treatment sequence, so that an equal number of participants were allocated 
to the two different sequences. Allocation was concealed using opaque envelopes, which 
were only disclosed immediately after enrolment by a member of the research team (MF). 
Participant flow is illustrated in Figure (4).    
Participants were not made aware of whether the appliance they received was the active 
(i.e. Twin-Block) or Sham appliance. 
3.6 Statistics 
Data were analysed using Stata Statistical Software (Stata 14, StataCorp LP, Texas, 
USA). PSG and questionnaire data were analysed through a linear mixed-effect model, 
with baseline data entered as a covariate. The fixed effects entered in the model were 
‘treatment’, ‘sequence’, and ‘period’. A term to test for a possible carry-over effect was 
also entered. The term ‘participant’ was entered as a random factor. The model residuals 





transformed. The results were presented as mean ± standard deviation of the mean, unless 
otherwise stated in the tables. IGF-1 and diary data were analysed using a paired t-test. 
Intraclass correlation coefficients (ICC) were calculated to estimate intra-examiner 
reliability of AHI. The significance level was set at P = 0.05 (two-tailed). 
4 Results 
Three participants dropped out of the study, all from sequence 1. One of these withdrew 
during the early stages of the first treatment period (Twin-Block). This participant was a 
10.2 years old girl, with a skeletal Class II intermaxillary relationship, an overjet=8mm, 
and a BMI=16.0 kg/m2 (BMI%=5-85). The reason offered for this withdrawal was 
“living in a remote suburb, and difficulty in regularly coming to the clinic”. The second 
participant was a 10.0 years old boy, with a skeletal Class I intermaxillary relationship, 
an overjet=6mm, and BMI=28.1 kg/m2 (BMI%≥ 95th). This boy was identified as a very 
severe case of OSA (AHI  80 event/h), and therefore immediately referred to the 
paediatric clinic in Dunedin Hospital for sleep specialist support. A third participant was 
a 10.1 years old boy, with skeletal Class I intermaxillary relationship, an overjet=3mm, 
and a BMI% ≥ 95th). This participant withdrew from the study during the second 
treatment period (Sham MAS), because of a lack of cooperation and subsequently failure 
to show for appointments. Data collected from this patient, however, could be used for 
the analyses. 
Demographic data of the 16 participants enrolled in the study are listed in Table (1). The 
frequency of snoring reported by the parents was 6.1 ± 1.4 nights per week.  
The sample consisted of seven normal weight (BMI < 85th percentile), four overweight 
(85th < BMI < 95th percentile), and five obese children (BMI ≥ 95th percentile)55. Eight 





and one of Middle Eastern ethnicity56. Thirteen participants (81.2%) had an overjet ≥ 4 
mm. The most common medical condition reported by parents was eczema (n=6 
participants), followed by asthma (n=4), and hay fever (n=3). Most patients (n=9) did not 
report any regular use of medications throughout the study period, the time of 
administering the questionnaires, when asking parents about any medication that their 

















Oropharyngeal patency varied across participants, and was classified as Class II in one 
participant, Class III in six participants, and Class IV in nine participants20 (for details 
about the classification criteria see Chapter 1). Enlarged tonsils (≥ Class II51) were 
observed in twelve participants and normal in one participant. Three participants had 
tonsils removed.  
The cephalometric data of the sample are presented in Table (2). The cephalometric 
features indicated that twelve participants had skeletal Class I jaw relationships (ANB 
angle=2.9±2.5 degrees)21, and four participants had Class II, as revealed by an ANB 
angle ≥ 5 degrees21. 
A total of 16 participants (13 males, 3 females; average age 9.8±1.4 years) were finally 







Table 1 Demographic and clinical data of the study participants (n=16; 13 boys 
and 3 girls)  
Variable Mean SD Min-Max 
Age (years) 9.8 1.1 7.6-12.3 
Snoring (nights per week) 6.1 1.4 3.0-7.0 
Overjet (mm) 6.1 2.4 3.0-12.0 
BMI (kg/m2)   20.2 5.4 14.5-32.9 
BMI (z score) 0.84 1.2 -1.1-2.4 






Table 2 Cephalometric data of the study participants (n=16) 
Measurement Mean SD Min-Max 
1 SNA (deg) 80.2 3.5 72.0-86.0 
2 SNB (deg) 75.9 3.5 70.0-82.0 
3 ANB (deg) 4.2 1.8 0.5-7.0 
4 Wits (mm) -0.7 4.7 -11.0-5.5 
5 SN-MP(deg) 35.0 6.4 26.0-46.5 
6 MMPA(deg) 27.5 5.6 19.0-39.0 
7 LAFH (%) 55.2 2.1 52.0-59.0 
8 UIA(mm) 111.9 .1 8 99.0-122.0 
9 LIA(mm) 92.1 8.7 80.0-108.0 
10 Li-APog(mm) 2.4 2.4 -2.0-8.0 
11 Interincisal angle(deg) 128.4 7.9 116.0-141.0 
12 Upper lip/E-Line(mm) -0.1 2.8 -6.0-5.0 











4.1 PSG results 
The intraclass correlation coefficients for duplicate measurements of overall, supine and 
non-supine AHI were 0.97 (95% CI=0.88-0.99; p<0.001), 0.99 (95% CI=0.95-0.99; 
p<0.001), and 0.93 (95% CI=0.76-0.98; p<0.001), respectively. 
PSG results are summarised in Table (3) and illustrated in Figures (5-9). 
 
Compared to a Sham MAS, wearing an Active MAS resulted in 40% reduction in AHI 
(95% CI=0.5-0.8; p=0.002). The separate assessment of AHI in supine and non-supine 
 
Figure 5 Box plot showing overall AHI score before and after the Sham and Active 
appliances (blue boxes). Red boxes show the changes of AHI after each treatment 
intervention. Comparison between the two treatment modalities showed a significant 
treatment effect (effect ratio = 0.6; 95% CI=0.5-0.8; p=0.002). Treatment effect 





sleeping positions revealed that only the former was significantly influenced from 
treatment, with a reduction of 4.1 events per hour (95% CI=1.8-6.4; p<0.001). Snoring 
time when wearing the Twin-Block was 46.3 minutes shorter than wearing the Sham 
appliance (95% CI=14.5-78.1; p=0.004).  
A significant increase in oxygen saturation (+0.5%; 95% CI= 0.1-1.0; p=0.017) resulted 
from the Active MAS treatment, when compared to the Sham MAS. The lowest recorded 
oxygen saturation showed a significant increase with the Active MAS, compared to the 
Sham MAS (+3.4%; 95% CI= 0.9-5.9; p=0.007). On the other hand, oxygen desaturation 
variables did not show significant differences between Active and Sham MAS treatment, 
particularly oxygen desaturation index (ODI) (p0.05). 
There was no evidence of carry-over effect for any of the PSG variables (p>0.05). This 
indicates that two weeks’ wash-out period was sufficiently long to allow the wash-out of 






Table 3 PSG results using Twin-Block versus Sham MAS.  The results are presented as mean ± standard deviation, unless differently 
indicated.   









(TB Vs. Sham) 
95% CI p 
AHI (event/h) 2.8 (3.0) 1.9 (2.1) 2.4 (3.0) 3.7 (4.7) 0.6 b 0.5, 0.8 0.002** 
AHI_supine (event/h) 4.7 (6.7) 2.2 (3.2) 3.8 (7.4) 5.7 (7.3) -4.1 -6.4,-1.8 <0.001** 
AHI_non-supine (event/h) 2.2 (2.2) 1.5 (1.7) 1.8 (2.1) 2.3 (2.8) -0.8b -2.0, 0.4 0.176 
Average oxygen saturation (%) 96.8 (1.0) 97.2 (0.7) 95.7 (4.6) 96.6 (0.9) 0.5 0.1, 1.0 0.017* 
Lowest oxygen saturation (%) 85.4 (11.3) 90.6 (5.2) 87.9 (10.6) 89.1 (5.3) 3.4 0.9, 5.9 0.007** 
Average oxygen desaturation (%) 3.8 (0.4) 8.7 (20.9) 3.7 (0.6) 3.6 (0.4) -0.3 -0.8, 0.2 0.287 
Number of desaturation events (event/h) 22.1 (23.0) 15.6 (12.7) 28.3 (32.7) 32.5 (32.9) 0.6 b 0.3, 1.2 0.146 
ODI (event/h) 2.3 (2.2) 1.7 (1.4) 2.8 (3.0) 3.4 (3.1) 0.7 b 0.5, 1.1 0.105 
Snoring time per night (min) 52.9 (61.8) 39.0 (51.5) 46.0 (61.8) 73.7 (108.4) -46.3 -78.1,-14.5 0.004** 
Number of snoring episodes per nightc 82.0 (190.0) 42.0 (85.0) 61.5 (95.5) 51.0 (111.5) 0.5a 0.2, 1.5 0.250 
Snoring time / total sleeping time (%) 9.9 (11.7) 7.5 (10.1) 8.5 (11.7) 13.5 (20.2) 0.6 b 0.3, 1.1 0.080 
Longest Snoring Episodes (min) 8.6 (11.2) 8.4 (10.7) 7.1 (7.0) 11.0 (13.6) 0.8 b 0.5, 1.4 0.455 
HR (Bpm) 75.3 (12.6) 74.4 (8.2) 72.4 (8.7) 75.1 (9.5) 1.0 a 0.9, 1.0 0.099 
Polysomnographic data were analysed through a linear mixed-effect model, and log-transformed. Zero data were corrected by adding one.  
Abbreviations: Apnoea hypopnoea index (AHI); oxygen desaturation index (ODI); heart rate (HR). 
a Log-transformed for linear mixed model analysis; treatment effect is the ratio of geometric means 
b Log-transformed after adding one (due to zero values) for linear mixed model analysis; treatment effect represents the ratio of geometric means  






Figure 6 Box plot showing supine AHI score before and after the Sham 
and Active appliances (blue boxes). Red boxes show the changes of AHI 
after each treatment intervention. There was a significant treatment effect 
of -4.1 events per hour (p<0.001) 
 
Figure 7 Box plot showing non-supine AHI score before and after 
the Sham and Active appliances (blue boxes).  Red boxes show the 
changes of AHI after each treatment intervention. The treatment 







Figure 8 Box plot showing snoring time before and after the 
Sham and Active appliances (blue boxes).  Red boxes show the 
changes of snoring time after each treatment intervention. 
There was a significant treatment effect (p=0.004) 
Figure 9 Box plot showing snoring episodes before and after 
the Sham and Active appliances (blue boxes).  Red boxes show 
the changes of snoring episodes after each treatment 







4.2 Secondary outcomes results  
IGF-1 levels after wearing the Active MAS were 221 ± 129.3 ng/mL, and 204 ± 116.9 
ng/mL after wearing the Sham MAS. The difference between the Sham and Active 
intervention was not statistically significant (p=0.172). 
The data collected using the diaries, summarised in Table (4), were used to estimate the 
percentage of snoring nights over each three-week treatment period. The percentage of 
nights with snoring was lower with the Twin-Block MAS (23%) than with the Sham 
MAS (43%; p=0.017).  
Reports of the appliance wearing time indicated that both appliances were regularly worn 
for over 90% of the prescribed time. A few problems were reported in the first few days 
of treatment, so some of the patients experienced initial discomfort when wearing the 
appliances, such as salivation, feeling pressure, and experiencing dental pain for a short 
period in the morning after wearing the Active MAS. All of these problems were 
alleviated in the first week of wearing the appliances. One problem reported by some 
parents was lack of retention of the appliance, particularly the maxillary plate of the 
Active MAS, due to using vertical elastics to maintain the mandible in the right forward 
and vertical position. This problem was solved by adjusting the appliance to increase 
retention and resistance to the action of vertical elastics. 












4.3 Questionnaire results 
Most of the children in the study (n=14; 88%) had a baseline PSQ score  0.33, which is 
considered the critical threshold suggestive of high risk for sleep-disordered breathing43. 
PSQ scores were significantly influenced by the treatment, and decreased with the Active 
MAS treatment, compared to the Sham MAS (p=0.012). Similarly significant changes 
were detected in the quality of life questionnaire OSA-18, as shown by the significant 
improvement in TSS scores with the Active MAS, compared to the Sham MAS 
(p=0.028). Table (5) 
Table 4 Parental reports of snoring frequency, appliance use, and participants’ 
adherence per treatment period (length = 21 days). The results are presented as 
mean ± standard deviation. Data were analysed through paired Student’s t test 
unless differently indicated. 
 Twin-Block 
 
Sham MAS      P 
Number of nights wearing appliance  
 
20.4 ± 0.8 20.4 ± 0.9 1.000 
Number of nights wearing the appliance full 
time 
18.9 ± 2.1 19.1 ± 2.4 0.923 
Number of nights snoring  4.6 ± 4.7 8.5 ± 6.1 0.017a,* 
Number of nights snoring (%) 23.0% ± 24.0 43.0% ± 31.0 0.036* 
Number of nights where parents don't know 
if a child was snoring 
4.7 ± 6.9 5.5 ± 7.1 0.619 
 
Number of nights with missing data  
 
 
0.1 ± 0.4 
 
1.1 ± 1.7 
 
0.054 
a data were analysed through a linear mixed-effect model 






Improvement was observed in behaviour (BASC-2 BESS questionnaire) after wearing 
the Active MAS, compared to the Sham MAS, as T score changes were significantly 










Table 5 Questionnaire results using Twin-Block versus Sham MAS The results are presented as mean ± standard deviation, 










(TB vs Sham) 
9 5% CI     P 
PSQ 0.44 (0.2) 0.32 (0.2) 0.39 (0.1) 0.42 (0.2)        1.08a 1.02, 1.14 0.012* 
OSA_18  (TSS score) 45.6 (14.8) 35.7(15.2) 40.8 (8.8) 41.8 (14.4)        8.9 1.0,16.8 0.028* 
BASC-2 BESS (T score)
   
51.1 (11.3) 48.4(12.1) 48.8 (14.0) 50.1 (9.7)        5.0 1.3, 8.7 0.008** 
Questionnaire data were analysed through a linear mixed-effect model, and log-transformed. Zero data were corrected by adding one. 
Abbreviations: PSQ = Paediatric Sleep Questionnaire; OSA-18 = Obstructive Sleep Apnoea Quality of Life Questionnaire; TSS = Total 
Symptom Score; BASC-2 = Behaviour Assessment System for Children, Second Edition; BESS = Behavioural and Emotional Screening 
System. 
a Log-transformed after adding one (due to zero values) for linear mixed model analysis; treatment effect represents the ratios of geometric 
means after adding one. 
* significant changes P≤0.05, ** significant changes P≤0.01 
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4 Discussion  
1 Discussion of the results 
1.1 PSG results 
The findings of this randomised controlled trial suggest that the Twin-Block appliance 
may be an effective short-term treatment for SDB in selected children with a Class II or 
Class I malocclusion. Compared to the Sham appliance, the use of the Twin-Block 
resulted in significantly lower AHI scores, an increase in the minimum and average 
oxygen saturation, and a reduction in snoring time.  
The overall AHI represents a combined measure of supine and non-supine AHI, and was 
used as the primary outcome measure of this RCT. Interestingly, the AHI score at 
baseline was more severe in the supine position than the overall AHI, thus indicating that 
participants exhibited more position-related OSA prior to treatment. A relationship 
between body position and OSA severity in SDB children has been reported in previous 
studies1-3, and consistently higher AHI values have been reported in the supine position 
in adults with OSA4. Supine-related OSA is possibly due to unfavourable airway 
geometry, reduced lung volume, and an inability of airway dilator muscles to adequately 
compensate as the airway collapses, particularly during REM sleep5. It is therefore not 
surprising that the effect of the Twin-Block was more pronounced when children were 
sleeping in the supine position, as revealed by changes in supine AHI. 
The main criterion for recruiting study participants was heavy snoring, as reported by 
parents. Nonetheless, the vast majority of the participants included in the final sample 
were confirmed to have OSA. When considering the results of the two baseline 
abbreviated PSG studies, the vast majority of participants (i.e. 87%) presenting with 







parentally reported habitual snoring scored an AHI ≥ 1, and only two participants scored 
an AHI  1. Average OSA severity in the sample was mild (12 cases with an AHI=1-5 
event/h). One participant had moderate OSA (AHI=7.7 event/h), and another had severe 
OSA (AHI=11.7 event/h). Hence, our findings can be generalised not only to children 
with heavy snoring, but also to children with different degrees of OSA. 
AHI values in the current study were assessed using the Level 3 home-based abbreviated 
polysomnography (cardio-respiratory) 6 and estimates of arousals depended on 
actigraphy movement artefact and listening to audio recordings. Portable home-based 
monitors show good diagnostic accuracy compared to Level 1 sleep tests in adults with 
a high pre-test probability of moderate to severe OSA and no unstable comorbidities7. 
Thus they provide a useful additional diagnostic tool for the management of patients with 
uncomplicated OSA7, 8. In contrast, Level 3 PSG in children has been shown to 
underestimate AHI compared to Level 1 in-lab full PSG, which remains the gold standard 
for the evaluation of OSA. This underestimation can be due to missed hypopneas causing 
arousals without desaturation9. The abbreviated PSG, however, represents a more 
accessible and less expensive alternative to in-lab PSG and recording several channels of 
data (e.g., oximetry, airflow, respiratory effort), thus allowing the assessment of the AHI. 
Unlike Level 1 studies, Level 3 sleep studies cannot detect sleep stages, accurately 
measure sleep duration, or identify arousals7. This limitation should be taken into 
consideration when comparing the results of the current study with previous studies using 
Level 1 PSG. 
PSG results of the current study are in agreement with previous studies in children, which 
found significant reduction in AHI following mandibular advancement treatments, 
ranging from 53% to 75%10-12. The reported decrease in the previous studies is greater 







than that seen in the current study (31% reduction in overall AHI). Beyond the 
methodological flaws in the previous studies, this may be due to fact that previous studies 
have a longer follow-up (6-12 months) and recruited participants through sleep clinics, 
who were already confirmed to have moderate to severe OSA on average. In the present 
research, we recruited habitual snorers, and ended up with a group with mild OSA on 
average. Indeed, there appears to be a relationship between OSA severity and the 
magnitude of patients’ PSG response to a specific treatment. This applies both to 
children13 and adults14, with a larger reduction of AHI in patients with more severe OSA.  
In the present study, active MAS treatment showed an average decrease in the overall 
AHI and AHI in the supine position of 31% and 53% respectively. The reduction of 
supine AHI cannot be compared to previous studies using MAS in children, as they did 
not assess position-related AHI. This amount of reduction would be considered clinically 
significant according to one of the common definitions of successful OSA treatment, 
which is a reduction of ≥50% in AHI15, 16. According to this definition, seven participants 
(44% of the sample) were successfully treated with the Active MAS, showing ≥50% 
reduction in overall AHI, and eight participants (50% of the sample) showed ≥50% 
reduction in AHI in supine position. A reduction in the AHI to less than one event/hour 
is another criterion for successful treatment of OSA, and means a complete resolution of 
OSA symptoms. When adopting this stringent definition, five participants (31% of the 
sample) were successfully treated with the Active MAS, showing overall AHI and supine 
AHI  1 event/h after treatment.  
Variations in response to the Twin-Block treatment may be due to the multifactorial 
nature of SDB, considering the different aetiologies that cause narrowing of the 
oropharyngeal airway, such as obesity, adenotonsillar hypertrophy, or retrognathia, 







which can lead to airway obstruction17. Another possible reason for this variation in 
response is the wide range of SDB severity included in the study, from primary snoring 
(2 participants) to severe OSA (1 participant). Such variation in response to MAS 
treatment has also been reported in adults, when the use of MAS resulted in complete 
resolution of OSA in 35-40% of patients14, 18, 19. When adopting more liberal criteria in 
assessing successful treatment of AHI reduction  50%, more than 70% of adult patients 
experience a successful response to MAS treatment14, 18, 19. On the other hand, four 
participants (25% of the sample) in the present study showed an increase in AHI 
following MAS. The average increase in the AHI of this group of non-responders was 
0.6 ± 0.4 events/hour. Such a failure in treatment was reported in a study on MAS in OSA 
adults, and it was estimated to have occurred in 37.5% of patients14.  
The positive effect of the Twin-Block versus the Sham Appliance on both overall and 
supine AHI may be slightly inflated by an unfavourable response to the Sham MAS. 
Indeed, with the use of the Sham MAS, the AHI showed a tendency to increase after 
treatment. This may due to the inevitable bite opening of 0.5-1 mm with the Sham MAS 
(upper and lower Hawley retainers), because of the retention clasps on posterior teeth. 
Such an increase in the relationship between bite opening and AHI score has been 
reported in adults20. Another possible cause is the acrylic base plates, which cover the 
palate and the lingual side of the mandibular dental arch, and may occupy some of the 
tongue space and push the tongue to a slightly backward position. Moreover, several 
participants were suffering from the flu or common cold during a sleep study at the end 
of one treatment period, which caused an increase in abbreviated PSG evaluated AHI 
compared to baseline recordings, and this may have played a role in AHI changes 
observed during the study. We were able to control this problem at the time of baseline 







recording by postponing the PSG study until complete resolution of cold symptoms, but 
this problem was not well controlled in the PSG studies at the end of the treatment period. 
This was a possible reason for the recorded variation in response in both treatment 
periods, Sham and Active MAS. However, uncertainty still remains as to why the AHI 
increased in four patients in response to the Sham appliance, and this factor needs to be 
considered in future treatment studies in children.  
Slight but significant improvements were observed in the average and lowest levels of 
oxygen saturation with the Active MAS in comparison to Sham MAS. In contrast, the 
few available previous studies using MAS in paediatric OSA patients showed 
insignificant changes in oxygen saturation10, 12, 21. Unlike in adults, oxygen saturation 
shows variations in paediatric OSA. Changes in oxygen saturation are not well correlated 
with AHI changes, and children do not show significant changes in oxygen saturation 
unless they have severe OSA. This may due to the fact that OSA in children results in 
arousals and sleep fragmentation without significant desaturation. In addition, lots of 
movement artefact may be recorded because children tend to move a lot during sleep 22. 
1.2 Snoring 
Snoring is the most commonly manifested symptom in children with SDB, and its 
detection is a key element in diagnosis. This is important, because studies showed that a 
significant number of habitual snoring cases, more than a third in one study, progress to 
OSA23, and habitual snoring has a significant negative health impact on children, with 
neurobehavioural consequences23-27. In the current study, subjective ratings of snoring 
frequency improvement by parents differed significantly between the Twin-Block and 
the Sham treatment. Subjective ratings were consistent with the analysis of audio 
recordings of snoring, which showed a significant reduction in the total time, but not in 







the number of snoring episodes, assessed during the Active and Sham MAS treatment. 
Previous studies on the use of oral appliances in OSA children have not assessed snoring, 
and therefore our findings cannot be compared to previous ones. Our preliminary 
findings indicate that the analysis of snoring with audio recordings may represent a 
promising tool for monitoring SDB. Further research, however, is required to confirm its 
validity and reliability28-30. During the study, it was found that the microphone plug of 
one of the recording units was faulty. This resulted in some low quality audio recordings, 
which made 14 of these (22% of the recordings) difficult to analyse. Low quality sound 
records were discarded and treated as missing data.  
1.3 Growth hormones 
Growth hormones was indirectly evaluated by measuring serum levels of IGF-1 after 
using the Twin-Block, and compared to levels after using the Sham MAS. No significant 
differences were detected in IGF-1 levels between the two treatments, although they 
tended to be higher after use of the Twin-Block. Failure to detect significance may be 
due to the limited power of this statistical test, to the wide range of IGF-1 norms in a 
specific age group, and to large differences in norms among different age groups, which 
vary widely over one year intervals31. Previous studies showed that reduction in AHI is 
associated with improvement in growth hormone levels after adenotonsillectomy32. The 
trend toward increased levels of IGF-1 in blood when using the Twin-Block warrants 
further investigation to confirm its significance. Previous reports on the efficacy of 
mandibular advancement splints for growth modification treatment showed that jumping 
the bite resulted in an increase of the mandibular length by enhancing mandibular 
growth33, 34, due to the direct effect of MAS on temporomandibular joint growth35. It is 







possible that increased serum levels of growth hormone during MAS treatment can 
enhance mandibular growth. This hypothesis should be tested in future research.  
1.4 Pediatric Sleep Questionnaire  
Parentally reported SDB symptoms are commonly used for screening children suspected 
to have SDB, and the validated 22-item Paediatric Sleep Questionnaire (PSQ) has a 
sensitivity of 0.85 and a specificity of 0.8736, which can be considered as reasonable. Our 
PSQ findings showed that SDB symptoms improved with Twin-Block treatment, and 
this improvement may be the consequence of a reduction in AHI. This observation 
supports the validity of parents’ observations in detecting changes in SDB symptoms, 
which were consistent with the objective assessment with PSG in this study. The 
participants showed a trend towards a “normal range” of PSQ scores (i.e. PSQ  0.33) 
after Twin-Block treatment. The results of the current study are in agreement with 
previous findings by Villa et al.11, which showed significant improvement in SDB 
symptoms after MAS treatment. In Villa’s study, however, SDB symptoms were 
assessed using the Brouillette questionnaire37, which was filled in by parents before and 
after treatment with oral appliances11.  
1.5 Quality of life OSA-18 
OSA-18 has been suggested as a useful tool in predicting OSA severity, but no significant 
correlation between the severity of paediatric OSA and OSA-18 has been found45, 46. 
Positive changes have been reported in quality of life in children with OSA after 
adenotonsillectomy and rapid maxillary expansion47, 48. In the present study, a significant 
reduction in OSA-18 TSS score was detected with the Twin-Block treatment in 
comparison to the Sham treatment, but an average TSS score of OSA-18 prior to 
treatment was within the normal range (TSS  60), suggesting that the OSA cut-off may 







not have been appropriate. A recent study (Kobayashi et al., 2014) showed that using a 
lower TSS cut-off, set at 40, resulted in 100% sensitivity when screening OSA patients. 
This was just 51.1% at the original cut-off point of 60, when Franco et al. proposed the 
OSA-18 in 200049. This may enhance the clinical significance of the results of the current 
study, and suggest an association between use of the Twin-Block and clinically 
significant improvement in SDB-related quality of life in children. 
1.6 Behavioural assessment (BASC-2 BESS) 
A brief BESS questionnaire level two (ages 6-11), containing 30 items, was used in our 
study. BESS is designed to quickly screen children’s behavioural and emotional changes. 
In the current study, the calculated T score showed significant positive changes in 
participants’ behaviour in the Twin-Block period, compared to the Sham MAS period. 
Seven participants showed an above normal T score (T  50), but the average calculated 
T score was close to normal on the four occasions when the BESS questionnaire was 
administered (baseline T scores= 51.1 ± 11.4; 48.8 ± 8.7 in Twin-Block and Sham-MAS 
periods respectively). The positive behavioural changes when using MAS in the current 
study are in agreement with reported positive behavioural changes after 
adenotonsillectomy, due to the resolution of obstruction in the upper airway50. 
1.7 Nocturnal Enuresis  
Nocturnal enuresis is an important sign of OSA51, and previous findings suggest that oral 
appliances, particularly rapid maxillary expansion, can reduce enuresis in paediatric 
OSA52. Adenotonsillectomy can also reduce enuresis in children with adenotonsillar 
hypertrophy53. Therefore, in the current study, we collected parental reports of 
bedwetting to explore the possible effect of MAS on enuresis. Enuresis in children with 
suspected SDB is highly prevalent in those under seven years of age54, 55. This may 







explain why the current study, which recruited snorers in the age range from 8 to 12 
years, failed to include patients who experienced bedwetting, especially when 
considering that the incidence of enuresis in 10-year-old children is estimated at 
approximately 5%, and this rate decreases every year, until only 1% continue to 
experience nocturnal enuresis into adulthood56. 
2 Problems reported by parents, treatment adherence and attrition rate 
Although the Twin-Block appliance was well tolerated by children, some parents (of four 
children) reported that it was sticking off the maxillary arch. Consequently, this 
demanded adjustments to increase the appliance retention. Some initial discomfort was 
also reported, which was gradually alleviated in the next few days. Acceptance of the 
appliance was evident through parents’ diary reports. Both appliances were regularly 
worn for over 90% of the prescribed treatment time of three weeks. In addition, the few 
withdrawals from the study were not for reasons related to the treatment. One participant 
lived in a remote area, one parent failed to cooperate, and a third participant was 
diagnosed with a very severe sleep apnoea (AHI  80 event/h) from the abbreviated-PSG 
study, and was thus referred urgently to a sleep specialist for full assessment and 
treatment. The fact that none of the patients abandoned the therapy because of problems 
tolerating the active treatment indicates that MAS, particularly Twin-Block, may be 
suitable for treating SDB children. In the current study, joining the upper and the lower 
pieces of Clark’s Twin-Block together with vertical elastics allowed a degree of lateral 
and vertical lower jaw movements, and consequently enhanced compliance. Generally, 
the Twin-Block holds significant features to make it relatively well tolerated and easily 
titratable to obtain an incremental advancement of the lower jaw57. The Twin-Block can 
also expand the upper arch58, is suitable for both mixed and permanent dentitions58, and 







has a low failure rate59. The therapeutic rationale of using a Twin-Block in SDB cases is 
that the majority of orthodontic anomalies (except Class III-protruded mandible) benefit 
from mandibular advancement capable of enlarging the retrolingual space, and at the 
same time, this promotes lingual advancement10, 11.  
3 Strengths of the Study 
This study has several strengths. Firstly it was designed as randomised control trial, 
which represents the gold standard for the evaluation of therapeutic effectiveness60. 
Therefore, unlike previous studies, the current study provided new robust and reliable 
information about the possible efficacy of MAS for the management of SDB in children. 
Another strength is the crossover design of the current study, which has previously been 
used to examine the efficacy of oral appliances in adult patients with obstructive sleep 
apnoea61-63. The study design allowed each participant to act as his/her own control, thus 
increasing the power of the statistical tests and precision of estimates. This study also 
systematically addressed the efficacy of MAS on other important health outcomes related 
to SDB, such as quality of life and neurobehavioural functioning, using validated 
questionnaires. These outcomes have not been widely addressed in previous intervention 
studies investigating paediatric snoring or OSA64. 
The adequate power for the main outcome variable, the multivariate approach to data 
analysis, and the low attrition rates represent further strengths of this research.  
Although this could not be considered a double-blind RCT, our study participants were 
not told which appliance was expected to be active. Furthermore, the sleep physiologist 
who scored the PSG data was blinded to all participants’ information and treatment type. 
This sleep physiologist was a registered Respiratory and Sleep Physiologist, with 







extensive experience in the technology of sleep laboratories in Australia and New 
Zealand. The statistician analysing the study results was also blinded to the treatment 
intervention.  
The use of validated devices for home based PSG is another strength of the current study. 
Indeed, the Embletta monitors used in our research have been previously validated for 
the diagnosis of SDB65-68.  
4 Study limitations 
This study had some limitations, the main one being the short duration of treatment 
intervention (i.e. 3 weeks for each treatment period). Further research with a longer 
duration of treatment is required to confirm the medium- to long-term effect of MAS. 
Although this study had adequate power for statistical testing of AHI, the sample size 
should still be regarded as small, with limited power in testing some of the secondary 
outcomes, such as IGF-1. However, this study provided preliminary findings that can be 
used for planning further research in the field. 
This small study sample may not be representative of SDB in the broader population of 
children. Furthermore, the SDB manifestations of study participants were rather broad, 
ranging from primary snoring to severe OSA. A larger sample size would also be needed 
to explore the efficacy of MAS in relation to SDB severity, site of upper airway 
obstruction, obesity, and other factors that may play a role in response to MAS treatment.  
Although the majority of patients presented with Class II incisor relationship the sample 
included a skeletal Class II and Class I inter-maxillary relationship. In patients with a 
normal inter-maxillary skeletal relationship (i.e. Class I) the use of a Twin-Block for 







prolonged periods of time may be contraindicated, as it may result in unfavourable facial 
growth modification and unwanted dentoalveolar changes. 
The Sham appliance still influenced mandibular and tongue posture, and therefore it 
could not be considered as a non-active placebo control condition. Interestingly, an effect 
on SDB and related symptoms in association with the use of control or sham appliances 
has previously been reported in adults19, 69-71, but not in children. The construction of an 
intraoral placebo appliance can be very challenging or even impossible in orthodontic 
research because when intervention studies involve procedures rather than pills, sham 
procedures take place to match the experience of the treatment as close as possible72. In 
SDB trials, however, it is very important to have a control condition, because even the 
use of a placebo tablet for the management of SDB may have a significant influence on 
SDB symptoms73.  
Finally, an additional limitation of this study is the use of subjective assessments for 
several secondary outcomes, such as parental reports with diaries, which may not be 
accurate or valid.  
5 Future directions  
In future research, the effectiveness of MAS should be compared with the primary 
treatment, ‘adenotonsillectomy’. This may confirm the indication of MAS as an 
alternative treatment option for paediatric OSA. More research is also needed to 
investigate possible sources of variations in response to MAS treatment. These sources 
may include OSA severity, obesity, tonsil size, and the site of upper airway obstruction.  
Some parents reported that the main issue with the Twin-Block was their child’s inability 
to retain the splint on the maxillary arch. Therefore, adding modifications to the Twin-







Block design may be necessary to enhance the retention of this appliance to the teeth and, 
consequently, to ensure that the lower jaw remains in the forward and vertical position, 
which is known to be favourable to the expansion of the oropharyngeal airway during 
sleep.  
Increasing evidence has emerged about the efficacy of rapid maxillary expansion (RME) 
in paediatric OSA64. It is worth comparing RME with MAS in a future randomised 
controlled trial, considering the significant effect of MAS use in OSA children in the 
current study. Furthermore, combining these two orthodontic modalities (MAS & RME) 
may have a favourable effect on paediatric OSA, and should be investigated in a study 
using adequate controls. Combined MAS and RME treatment may be more effective than 
using just one modality, as the mode of action differs between the MAS treatment and 
the RME appliances. MAS targets the mandible by forward repositioning along the 
sagittal and vertical planes, and RME targets the upper jaw by transverse expansion. 
In addition to combining orthodontic appliances, other appliances should also be 
considered and tested. For example, mandibular arch expansion in selected cases may 
play a role in alleviating paediatric SDB by providing more space for the tongue. 
Appliances used for the treatment of Class III intermaxillary skeletal cases (maxillary 
retrusion and/or mandibular protrusion) may expand the upper airway and the space of 
the tongue. All of these appliances are worth exploring in future studies, and this may 
enhance the role of orthodontic appliances in the field.  
Developing a robust method for snoring diagnosis is important, as our preliminary 
findings showed that the analysis of audio recordings of snoring may represent a 
promising method for detecting and monitoring SDB. Snoring is considered the main 
manifestation of paediatric SDB22. Further research is required to develop an objective 







analysis method to determine snoring frequency and intensity in children, and relate this 
to aetiologic factors such as upper airway obstruction (severity and site of obstruction). 
Employing this method in SDB diagnosis and monitoring will be valuable after 
confirming its validity and reliability. 
The findings of this study, which demonstrated a trend of IGF-1 changes after the Twin-
Block treatment, are worth further investigation to confirm the possible effect of MAS 
treatment on the serum levels of growth hormone. If the relationship between MAS use 
and increased growth hormone serum levels can be proven to be significant, then this 
will enhance the role of MAS as a tool for mandibular growth modification. These 
appliances have already been used for decades to encourage mandibular growth in Class 
II intermaxillary cases, but on the basis of the direct effect of MAS on 
temporomandibular joint growth35. An additional potential outcome of these appliances 
is worth considering i.e. enhancing growth hormone secretion. 
6 Conclusion 
1 Short term use of the Twin-Block appliance seems to help in the treatment of OSA 
in children 
The short-term use of the Twin-Block appliance was found to significantly reduce 
overall AHI and supine AHI in children with SDB. Wearing the Twin-Block 
appliance also resulted in decreased snoring time and a statistically significant 
increase in the average and lowest levels of oxygen saturation. Symptoms related 
to SDB, such as quality of life, behaviour, and paediatric sleep questionnaire 
scores, showed improvement when the Twin-Block was used.  
2- Long term/growth modification of mandibular deficiency in children with OSA 
should be evaluated 
3- Potential complementary effects of the use of Twin-Block appliance with 
adenotonsillectomy and/ or orthopaedic expansion of the maxilla should be evaluated. 
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Parents/ Caregivers Information Sheet  
Study title Efficacy of A Mandibular Advancement Appliance on Sleep 
Disordered Breathing  in Children 
Principal  
investigators 
Name Prof. Mauro Farella  
Department Discipline of Orthodontics, Department of 
Oral Sciences. 
Position Professor of Orthodontics, Head of Discipline 
of Orthodontics Contact  
Tel : 0 3 479 7084 
Email: 
kids.snoring@otago.ac.nz 
Name Dr. Ghassan Idris 
Department Discipline of Orthodontics, Department of 
Oral Sciences, School of Dentistry. 
Position PhD candidate. 
Thank you for showing interest in this project.  Please read this information 
sheet carefully. Take time to consider, and if you wish, talk with relatives 
or friends before deciding whether or not to participate.  





If you decide to participate we thank you.  If you decide not to take part 
there will be no disadvantage to you and we thank you for considering our 
request.  
 
Why are we doing this study? 
The aim of our research is to test the efficacy of mandibular advancement 
appliances in treating children with sleep disordered breathing (SDB).  
Mandibular Advancement Splints (MAS) are devices place the lower jaw in advance 
position. MAS are one of the most acceptable orthodontic functional appliances; 
MAS are mainly used in treatment of underdeveloped lower jaw, and this study will 
test the efficacy of MAS in improvement of the main symptoms of SDB such as 
snoring and stopping breathing during the night, and other secondary symptoms 
such as quality of life, daytime sleepiness, and bed wetting. This study will also 
check potential changes that may happen to growth hormone levels as a result of 
the treatment.    
Who is funding this project? 
This project is funded by the University of Otago and New Zealand Association of 
Orthodontists and other funding bodies may also participate with the progress of 
this research. 
Who are we seeking to participate in the project? 
Introduction 
Children who snore may suffer from a problem called Sleep Disordered 
Breathing (SDB). SDB varies in intensity from just snoring to no breathing at 
all for a few seconds, which disturbs sleep. Although this disease has many 
negative effects on health but SDB is not recognised in most children with mild 
to moderate symptoms. The primary cause of SDB in children is the enlarged 
adenoids or tonsils which block the airways during sleep. On the other hand, 
the primary treatment for SDB is doing a surgery to expand the airways by 
removing these tissues.  
It is generally accepted that gradually moving the lower jaw forward in growing 
children may improve jaws and teeth relationships, and also increase the airway 
space thus improving the symptoms of SDB. This may offer an alternative 





We are mainly looking for children between 8-12 years old who snore regularly and 
loudly (about 3 times per week), without previous orthodontic treatment. 
If you participate, what will you be asked to do? 
At the first stage you will receive an information sheet about this study and a 
consent will be obtained from you and your child if you decide to participate.  
We will check if your child is suitable to receive the orthodontic treatment offered 
in this study; checking eligibility will be confirmed by evaluating and examining the 
following:  
 Face appearance, teeth and jaw relations.  
 Impressions of the teeth to get models. 
 X-rays of the teeth and the head.  
 Parents/caregivers will answer a questionnaire about SDB symptoms and 
severity.  
 An electronic monitor may be provided for a full night monitoring of SDB at 
home. 
Based on the results of the above investigations, suitable children will be invited to 







Figuer 1- The monitor  which will be used in the study for 
SDB monitoring at night. 
 
Participants will be randomly divided into two groups, with 8 children in each group. 
All the children participating in the study will receive the same treatment with two 
MAS appliances (figure 2), but in different order as the following:  
 The first group will receive a treatment consisting of two periods: the first 
period of 3 weeks with an active MAS and the second treatment period of 
3 weeks with a reference MAS. Participants will have a 2 weeks break 
without treatment between the two treatment periods to avoid interlocking 
effect between the two appliances. 
 The second group will receive the same two MAS appliances but in different 
order (The reference MAS first then the active MAS and a break of 2 
weeks in between). 
The MAS appliance which is considered as a reference will serve as a control 
appliance to assess the efficacy of the effective MAS. The patients will not be 
informed about which of the two appliances they are wearing in a specific period 








Figuer 2- The MAS appliance which will be used in the study; consists of two splints 
for the upper and lower jaws 
 
Parents/ caregivers will be asked to answer questionnaires before and after each 
period of wearing the appliances and they will be provided with a diary to record 
bed wetting and snoring every week.  
Children will be provided with a monitor to observe the SDB symptoms including 
snoring, blood oxygen levels, and heartbeat, airflow in the nose, and many other 
measurements. This will be applied before and after each period (figure 1).  
A specialist in venipuncture will take blood samples by inserting a needle into a vein 
in the arm, as it is done routinely to take blood samples. This will not require any 
specific test preparation (such as fasting). Blood samples will be taken only twice 
throughout the study to check for possible positive changes in growth hormone 
levels in the blood after using MAS appliances.  
Treatment cost 
The treatment during the study is free of charge, but you will be charged after 
finishing the study if you want to continue your child’s orthodontic treatment at 
the School of Dentistry. One of the benefits of participating in this study is that 





for correcting the bite and a child can continue the remaining orthodontic 
treatment at the School of Dentistry with a high priority.   
What specimens, data or information will be collected, and how will they be used?  
Blood sample collection, storage, tests, and disposal of medical wastes will be done 
according to World Health Organization guidelines. Blood samples will not be stored 
but will be disposed off after getting the result of the tests. 
Other data collected in the study through clinical examination, X-rays, breathing 
and snoring monitors or questionnaires will be reviewed and analyzed by the 
research group. The collected data will be saved for 10 years at the Discipline of 
Orthodontics at School of Dentistry/ University of Otago. 
Is there any risk of discomfort or harm from participation? 
MAS appliances are well-accepted among children with a low failure rate. It is non-
invasive (does not require any surgery) but these appliances do need a period of 
adaptation. There might be mild levels of discomfort and/or tenderness of the 
facial muscles in the first few days your child wears the appliance, but this will 
disappear soon. Your child may also experience initial speech difficulties and 
excessive salivation for the first few days, but these problems will diminish over 
time. The appliance used in the study may slightly change your bite. This is very 
unlikely to happen over a few weeks of the MAS appliance use, but if this will be 
the case, the changes will be transitory and favourable to correct your bite. 
Collecting blood samples from the arm veins using a syringe with a needle is 
sometimes accompanied by anxiety, but we will collect blood only twice throughout 
the study. This procedure will be done by a specialist in venipuncture to guarantee 
a high quality procedure and to ensure the child’s comfort and minimizing any 
potential complication. 
What about anonymity and confidentiality? 
Personal information and the collected data from you and your child during the 
study which identify you will only be used by the researchers and people involved 
in evaluation and reviewing this study. The results of the study will be written up 
for the University work, and they may be written up in journals and talked about at 
conferences, but. Your identity will not be disclosed to anyone. 
If you agree to participate, can you withdraw later? 
You may withdraw from participation in the project at any time and without any 








If you have any questions now or in the future, please feel free to contact 
either: 
Name Prof. Mauro Farella 
Position Professor of Orthodontics. Head of 
Discipline of Orthodontics 
Department Oral Science/ School of Dentistry 
Contact  
phone number: 0 3 479 7084 
Email: 
kids.snoring@otago.ac.nz 
Name Dr. Ghassan Idris 
Position  PhD candidate 
Department Discipline of Orthodontics/ Oral 
Science, School of Dentistry. 
 
This study has been approved by the University of Otago Human Ethics Committee 
(Health). If you have any concerns about the ethical conduct of the research you 
may contact the Committee through the Human Ethics Committee Administrator 
(phone +64 3 479 8256 or email gary.witte@otago.ac.nz). Any issues you raise will 







Efficacy of a mandibular advancement appliance on sleep 
disordered breathing in children 
 Principal Investigator: Professor Mauro Farella 
 (Kids.sonoring@otago.ac.nz  Tel: 0 3 479 7084) 
CONSENT FORM FOR PARTICIPANTS 
Following signature and return to the research team this form will be stored in a secure place for ten 
years. 
Name of participant:………………………………………….. 
1. I have read the Information Sheet concerning this study and understand the aims of 
this research project. 
2. I have had sufficient time to talk with other people of my choice about participating in 
the study.   
3. I confirm that I meet the criteria for participation which are explained in the 
Information Sheet. 
4. All my questions about the project have been answered to my satisfaction, and I 
understand that I am free to request further information at any stage.  
5. I know that my participation in the project is entirely voluntary, and that I am free to 
withdraw from the project at any time without disadvantage. 
6. As a participant, I know that the results of the project may be published and will be 
available in the University of Otago Library (Dunedin, New Zealand) but every 
attempt will be made to preserve my anonymity and my child’s anonymity. 
7. I know that the questionnaires provided in the study will explore the things related to 
check for the sleep disordered breathing symptoms and changes in their severity, 
changes in our child behaviour also will be detected as well as quality of life. 
8. I understand the nature and size of discomfort or harm which are explained in the 
Information Sheet. 
9. I know that when the project is completed all personal identifying information will be 
removed from the paper records and electronic files which represent the data from the 
project, and that these will be placed in secure storage and kept for at least ten years.  
10. I understand that the results of the project may be published and be available in the 
University of Otago Library, I agree that any personal identifying information will 





remain confidential between myself and the researchers during the study, and will not 
appear in any spoken or written report of the study.  
11. I know that there is no remuneration offered for this study, and that no commercial use 
will be made of the data.  
12. At the end of the study, I consent to any remaining blood samples being disposed of 
using: 
Standard disposal methods, OR; 
Disposed with appropriate karakia 
 
I agree to take part in this project. 
Signature of participant:  Date: 
    
   
Signature and name of witness:  Date: 
   
   







Children’s Information Sheet 
A study about children who snore while 
they sleep. Would you like to help us 
in a research project using a device to 
stop snoring? 
 
We would like you to help us in a project that is trying to stop snoring in children. 
What I will be asked to do? 
First of all, come in to visit some people in the dental school where they will ask you a few 
questions about yourself and look at your teeth, face and the way you breathe. They will 
also take x-rays of your teeth and head so they can look at your jaw bones, teeth and throat. 
On another day you will be given a small machine to be used at bed time. We will attach 
some sticky things on you which will be joinend up to the machine so we can record: 
 The way you breathe, by putting stretchy bands around your chest and tummy 
 The air coming in and out of your nose, by sticking a piece of tubing on (like a 
moustache) 
 Your heart beat, by putting two sticky circles on your chest and one on your tummy. 
 How much noise you make while you sleep 
 A special light that glows red in the dark placed on to your finger 
 A special strip will attach to your leg 
We will give you a device to put in your mouth. This device is mainly made of plastic and 
small metallic parts and it is made to fit your teeth and mouth. It consists of two pecies ; 
one to hold with your upper teeth and the other to be held with your lower teeth. You are 
able to take the two pecies out of your mouth by yourself without any help. We will ask you 
to have the device for 3 weeks, after that you will stop using it for 2 weeks , then we will 
give you a new device to use for another 3 weeks. We will provide you with full information 
about how to use this device and how to overcome any problems when using it. 
During the treatment we will take some blood from your arm using a syringe; this procedure 
is to check if the device is useful in  making you grow better.  
Your Mum or Dad will complete some information about you before and during the research 
and they will answer specific questions about the changes they notice about you and your 
snoring after wearing the devices. 
You can come to meet us and ask more questions before you decide to say ‘Yes’ or ‘No’. You 





this project, just ask your Mum or Dad or the person who looks after you.This is a chance 
to learn a lot of exciting things about how your body works, and you might find it very 
interesting to have this and to stop snoring. Remember you can ask us any questions 
whenever you like. 
The people involved in the project are: 















I have  read this sheet, and it has also been explained to me by my Mum or Dad or 















Questionnaire for parents/guardians 
EFFICACY OF A MANDIBULAR ADVANCEMET 




    
 
Thank you for taking part in the Study. This is a questionnaire about your child‘s 
 sleep and daytime activities and your family. 
  
Please try and answer all the questions.  If you feel uncomfortable about answering  
any question, or you do not know the answer, you can leave it blank, ask us for  
more information, or add a written comment.  
 





Discipline of Orthodontics  
Department of Oral Sciences  
University of Otago 
Tel 64 3 479 7084 
 
 
Please complete this section below. 
Name of person who completed this survey: _______________________________________ 


















Information regarding your child  
 
 
These questions are about your child.  For most questions, please circle the best 
answer.  For Yes/No questions, please answer ‘yes’ if this is something you have 
ever noticed in your child, even if it is rare or not currently a problem. 
For questions that require you to judge on a scale, please try to think about what 
your child is like most of the time.  Do not judge your answer based on a 
particularly good or bad day. 
 
1 What is your child’s ethnicity (please tick as many boxes as apply)? 
 New Zealand European 
 Maori (please specify iwi) _____________________ 
 Samoan 




 Other (please specify) _______________________ 




 Very good 
 Excellent 
  Yes No 
 3 Is your child currently on medication? If yes please provide the name of 
medication   















- Has your child had their adenoids removed? 
- Has your child ever had grommets? 
 
- Does your child suffer from any of the following? 
 Down Syndrome 
 Asthma 




Frequent sore throat. If yes, how often? 
_________________________________ 
 Glue ear 
 Hearing problems 
 None of the above 
- Has your child ever had any other serious medical conditions apart from those already mentioned? 
 
Yes. If yes, 
what?____________________________________________________ 
 No 
- Has your child ever been assessed and/or treated for developmental or behavioural problems? 
 
Yes. If yes, what was the problem? 
______________________________________ 
 No 
- What time does your child normally go to bed on weekdays?  
Time   :   AM/PM 
- What time does your child normally wake up on weekdays? 
Time   :   AM/PM 
- What time does your child normally go to bed on weekends? 
Time   :   AM/PM 
- What time does your child normally wake up on weekends?  
Time   :   AM/PM 


















How likely is your child to doze or fall asleep in the following situations… 
 









Sitting and reading 
    
24. 
Watching television 
    
25. 
Sitting inactive in a public place 
    
26. As a passenger in a car for an 
hour without a break     
27. 
Lying down to rest in the afternoon 
    
28. 
Sitting and talking to someone 
    
29. 
Sitting quietly after lunch 

























30. Loud snoring  
       
31. Breath holding or 
pauses in 
breathing at night 
       
32. Choking or made 
gasping sounds 
while asleep 
       
33. Restless sleep or 
awakenings from 
sleep  
       
34. Mouth breathing 
because of nasal 
obstruction 
       
35. A cold or upper 
respiratory 
infections 
       
36. Nasal discharge or 































swallowing food         
38. Mood swings or 
temper tantrums        
39. Aggressive or 
hyperactive 
behaviour  
       
40. Discipline 
problems         
41. Excessive daytime 
sleepiness        
42.  A poor attention 
span or 
concentration  
       
43. Difficulty getting up 
in the morning         
 
44. Caused you to 
worry about your 
child’s general 
health  
       
45. Created concern 
that your child is 
not getting enough 
air 
       
46. Interfered with 
your ability to 
perform daily 
activities  
       
47. Made you 
frustrated        
        
        


















48. How often does your 
child behave irritably 
during the day? 
      
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Table 5-1 Twin block results (apnoea hypopnoea index (AHI)) 
P Seq AHI_T1 AHI_Sup_T1 AHI_Nsup_T1 AHI_T2 AHI_Sup_T2 AHI_Nsup_T2 
1 1 7.7 21.8 7 4.9 6.2 4.4 
2 2 2.2 2.4 1.5 1.1 1.3 0.7 
3 2 1.0 1.1 1.0 0.2 0.0 0.3 
4 1 2.6 2.5 2.8 2.9 2.8 3.0 
5 2 11.7 20.5 7.2 8.4 12.6 6.0 
6 2 1.0 0.9 1.2 1.0 1.2 0.0 
7 1 1.8 1.5 2.7 2.7 3.2 0.6 
8 1 2.6 4.3 0.9 0.8 1.5 0.2 
9 1 1.2 1 1.6 0.6 0.6 0.6 
10 2 4.7 5.8 4.1 2.9 1.6 3.4 
11 2 0.6 0.2 1.3 0.1 0 0.1 
12 2 1.3 3 0.2 0.5 0 0.6 
13 1 0.3 0 0.3 1.3 1.2 1.4 
14 2 3.3 4 2.5 1.9 2.2 1.7 
15 2 2 6 0.4 0.7 0.8 0.7 
16 1 0.8 0 1 1 0 1 
Abbreviations P:participant number; Seq: sequence in the study sequence 1 started with Twin-
block followed by Sham MAS and sequence 2 started with Sham MAS followed by Twin-block;  
T1: sleep monitoring before  using Twin-block; T2: sleep monitoring last night of using Twin-
block (3 weeks);   AHI: apnoea hypopnoea index, AHI_Sup: AHI in supine position; AHI_Nsup: AHI 
in non-supine position  





Table 5-2 Twin block results (Oxygen level  measurements)  
P Seq O2Sat_T1 LoO2Sat_T1 O2Desat_T1 DesEvent_T1 ODIndex_T1 O2Sat_T2 LoO2Sat_T2 O2Desat_T2 DesEvent_T2 ODIndex_T2 
1 1 96.2 78 4.1 72 6.4 97.7 91 4.3 10 1.1 
2 2 97.6 90 3.7 15 1.6 97.7 91 4.3 10 1.1 
3 2 96.8 92 3.4 24 2.8 96.8 91 4.1 19 2.5 
4 1 97.1 88 4.3 32 3.4 97.5 90 3.9 31 3 
5 2 97.1 86 4.5 84 8.8 97.1 79 4.2 37 4.1 
6 2 97 93 3.3 9 0.9 96.5 93 3.4 11 1.4 
7 1 97.3 91 4.1 16 1.8  97.3 87 38 4.2 
8 1 97.2 93 3.4 13 1.2 97.2 93 3.2 17 1.6 
9 1 98.3 87 4.6 14 1.6 98.2 93 3.5 6 0.6 
10 2 96.6 50 3.5 10 1.1 96.8 78 3.3 3 0.3 
11 2 96.7 92 4 9 1.1 97 94 3.3 6 0.7 
12 2 97.2 77 3.8 5 0.7 97.9 91 4.3 4 0.5 
13 1 93.7 74 3.5 14 1.4 97.3 92 3.2 5 0.5 
14 2 96.9 90 3.6 18 2.1 95.7 91 3.5 22 2.7 
15 2 97.6 93 3.3 3 0.3 98.1 96 0 0 0 
16 1 96.4 93 3.2 15 1.7 96.6 89 3.5 31 3 
Abbreviations P: participant number; Seq: sequence in the study sequence 1 started with Twin-block followed by Sham MAS and sequence 2 started with Sham MAS 
followed by Twin-block; T1: sleep monitoring before using Twin-block; T2: sleep monitoring last night of using Twin-block (3 weeks); O2 Sat: Average Oxygen saturation; 







Table 5-3 Twin block (snoring measurement results) 
P Seq SnorTime_T1 SnoT%_T1 SnorEpis_T1 EpisDura_T1 LongstEpis_T1 SnorTime_T2 SnoT%_T2 SnorEpis_T2 EpisDura_T2 LongstEpis_T2 
1 1 18.2 2.7 82 0.2 1.1 23.1 4.1 78 0.3 1.5 
2 2 4.3 0.7 25 0.2 0.5 23.1 4.1 78 0.3 1.5 
3 2 11.3 2.2 48 0.2 0.9 9.8 2.2 30 0.3 1.5 
4 1 1 0.2 18 0.1 0.3 0.8 0.1 8 0.1 0.2 
5 2 56.8 9.9 160 0.4 20.7 52.7 9.8 40 1.3 28.3 
6 2 0.7 0.1 11 0.1 0.1 0.2 0 3 0.1 0.1 
7 1 134.6 24.8 303 0.4 22.4 137.2 25.1 186 0.7 12.5 
8 1 53.5 8.5 150 0.4 4.5 3.3 0.5 5 0.7 1.6 
9 1 0.1   2     13.2 2.2 44 0.3 3.9 
10 2 10 1.9 46 0.2 1.6 0.1 0 1 0.1 0.1 
11 2 49.3 10.2 139 0.4 15.4 17.3 3.2 64 0.3 7.8 
12 2 123.4 29.3 208 0.6 11 144.3 29.5 242 0.6 24.9 
13 1 58.1 9.7 169 0.3 4.1 6.8 1.2 36 0.2 1.9 
14 2 120.5 23.7 370 0.3 17.8 68.1 13.7 105 0.6 24.6 
15 2 204.6 34.9 292 0.7 37.6 123.8 24 116 1.1 24.6 
16 1 0.4 0.1 7 0.1 0.1 0.4 0.1 2 0.2 0.3 
Abbreviations P:participant number; Seq: sequence in the study sequence 1 started with Twin-block followed by Sham MAS and sequence 2 started with Sham MAS followed by Twin-block;  
T1: sleep monitoring before  using Twin-block; T2: sleep monitoring last night of using Twin-block (3 weeks); SnorTime: snoring time during sleep time (minutes); SnoT% : Relative snoring 
time to  whole sleep duration; SnorEpis: number of snoring episodes during sleep; EpisDura: Average snoring episode duration; LongstEpis: Longest snoring episode. 








Table 5-4 Sham MAS results (apnoea hypopnoea index (AHI)) 
P Seq AHI_S1 AHI_Sup_S1 AHI_Nsup_S1 AHI_S2 AHI_Sup_S2 AHI_Nsup_S2 
1 1 11.3 24 8.4 8.7 18.3 2.7 
2 2 1.4 1.3 1.8 1.1 1.6 0.3 
3 2 1.5 0.7 1.6 1.8 3.2 1.0 
4 1 3.3 4.0 3.0 9.3 11.0 8.6 
5 2 6.9 19.5 2.5 13.5 24.3 9.2 
6 2 1.1 1.3 0.0 1.2 1.4 0.7 
7 1       
8 1 2.6 4.2 0.7 5.7 9.2 1.6 
9 1 0.5 0.8 0 1 1.1 0.6 
10 2 0.5 0.5 0.6 2.4 1.7 3 
11 2 0.3 0.1 0.8 0.1 0.2 0 
12 2 2.3 0 3.4 2 3.7 0.6 
13 1 0.1 0 0.2 0 0 0 
14 2 0.1 0 0.2 1.3 1.3 1.3 
15 2 1.3 1 2.1 6.1 7.9 3.9 
16 1 2.3 0 2.4 1.4 0 1.5 
Abbreviations P:participant number; Seq: sequence in the study sequence 1 started with Twin-block followed by 
Sham MAS and sequence 2 started with Sham MAS followed by Twin-block;  S1: sleep monitoring before  using 
Sham MAS; T2: sleep monitoring last night of using Sham MAS (3 weeks);   AHI: apnoea hypopnoea index, 
AHI_Sup: AHI in supine position; AHI_Nsup: AHI in non-supine position  









Table 5-5 Sham MAS results (Oxygen level  measurements)  
P Seq O2Sat_S1 LoO2Sat_S1 O2Desat_S1 DesEvent_S1 ODIndex_S1 O2Sat_S2 LoO2Sat_S2 O2Desat_S2 DesEvent_S2 ODIndex_S2 
1 1 96.3 51 4.1 128 11.2 95.1 78 4.2 94 8.5 
2 2 97.6 90 4.7 26 2.5 97.8 89 4.5 20 2.2 
3 2 96.1 91 2.9 30 3 95.6 89 3.1 39 4.2 
4 1 96.9 88 4 49 5.1 96.6 85 3.8 116 11.4 
5 2 97.6 82 4.2 43 4.9 97.1 77 3.6 43 4.8 
6 2 96.8 90 4.3 6 0.7 96.9 94 3.3 11 1.3 
7 1           
8 1 97.2 93 3.1 15 1.5 96.7 93 3.3 11 1.3 
9 1 98.2 89 4.6 7 0.8 97.8 89 4.2 28 2.7 
10 2 95.2 90 3.5 23 2.5 96.2 92 3.3 12 1.2 
11 2 97.2 91 4.1 10 1.1 97.2 93 4 1 0.1 
12 2 79.2 94 3 9 1.1 95.6 91 3.5 30 3.2 
13 1 96.2 93 3 1 0.1 97 93 3 2 0.2 
14 2 97 92 3.6 14 1.4 97.1 93 3.1 7 1 
15 2 98 92 4 4 0.4 97.7 89 3.8 45 5.1 
16 1 96.4 93 3.1 59 6.3 95.3 92 3.4 29 3.2 
Abbreviations P:participant number; Seq: sequence in the study sequence 1 started with Twin-block followed by Sham MAS and sequence 2 started with Sham MAS followed by 
Twin-block;  S1: sleep monitoring before  using Sham MAS; S2: sleep monitoring last night of using Sham MAS (3 weeks); O2 Sat: Average Oxygen saturation; LoO2Sat: Lowest 
Oxygen saturation; DesEvent: number of desaturation events during sleep; ODIndex: number of desaturation events per hour of sleep.  







Table 5-6 Sham MAS (snoring measurement results) 
P Seq SnorTime_S1 SnoT%_S1 SnorEpis_S1 EpisDura_S1 LongstEpis_S1 SnorTime_S2 SnoT%_S2 SnorEpis_S2 EpisDura_S2 LongstEpis_S2 
1 1 7.7 1.1 5 1.5 6 10.2 1.5 7 1.5 6.1 
2 2 14.9 2.4 48 0.3 1.9 32.5 5.8 36 0.9 13.3 
3 2 26 4.3 80 0.3 1.6 24.9 4.4 66 0.4 1.1 
4 1 18.9 3.3 52 0.4 3.7 60.4 9.9 118 0.5 3.6 
5 2 43.7 8.3 60 0.7 11.3 57.9 10.8 95 0.6 11 
6 2 11.4 2.1 37 0.3 2.7 1.4 0.3 12 0.1 0.8 
7 1           
8 1 31.6 5.4 27 1.2 11.7 108.3 21.5 124 0.9 39.4 
9 1 67.6 13.1 93 0.7 10.8           
10 2 4.1 0.7 35 0.1 0.8 0.1 0 4 0 0 
11 2 6.8 1.2 25 0.3 1 0.1 0 2 0 0 
12 2 169.3 35.4 167 1 18.7 260.1 46.5 310 0.8 31.1 
13 1                     
14 2                     
15 2 188.9 32.1 218 0.9 21.1 326.2 61.6 294 1.1 25.2 
16 1 6.7 1.2 71 0.1 1.2 2.8 0.5 30 0.1 0.6 
Abbreviations P:participant number; Seq: sequence in the study sequence 1 started with Twin-block followed by Sham MAS and sequence 2 started with Sham MAS followed by 
Twin-block;  S1: sleep monitoring before  using Sham MAS; S2: sleep monitoring last night of using Sham MAS (3 weeks); SnorTime: snoring time during sleep time (minutes); SnoT% 
: Relative snoring time to  whole sleep duration; SnorEpis: number of snoring episodes during sleep; EpisDura: Average snoring episode duration; LongstEpis: 
Longest snoring episode 
Highlighted blank cells represent missing data 
 
  
